TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-379716	Cytosolic tRNA aminoacylation	5.03488764361838e-07	-14.5017044401076	24	10	0.0203252032520325	492	8202	833,2058,2617,3035,4141,8565,16,5464,6897,7453	CARS,EPRS,GARS,HARS,MARS,YARS,AARS,PPA1,TARS,WARS
R-HSA-379724	tRNA Aminoacylation	5.68622629548501e-07	-14.380048839808	42	13	0.0264227642276423	492	8202	833,79731,2058,2617,3035,10667,23438,4141,8565,16,5464,6897,7453	CARS,NARS2,EPRS,GARS,HARS,FARS2,HARS2,MARS,YARS,AARS,PPA1,TARS,WARS
R-HSA-73847	Purine metabolism	9.85497217678724e-05	-9.22494934762805	33	9	0.0182926829268293	492	8202	847,3251,2618,471,353,30833,3615,132,4907	CAT,HPRT1,GART,ATIC,APRT,NT5C,IMPDH2,ADK,NT5E
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.000398116617608455	-7.82876558653214	74	13	0.0264227642276423	492	8202	1912,8924,10274,197370,286053,22955,6612,348995,672,7518,648,23279,6015	PHC2,HERC2,STAG1,NSMCE1,NSMCE2,SCMH1,SUMO3,NUP43,BRCA1,XRCC4,BMI1,NUP160,RING1
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.000398116617608455	-7.82876558653214	74	13	0.0264227642276423	492	8202	1912,8924,10274,197370,286053,22955,6612,348995,672,7518,648,23279,6015	PHC2,HERC2,STAG1,NSMCE1,NSMCE2,SCMH1,SUMO3,NUP43,BRCA1,XRCC4,BMI1,NUP160,RING1
R-HSA-2990846	SUMOylation	0.000762964195778488	-7.17829945336606	79	13	0.0264227642276423	492	8202	1912,8924,10274,197370,286053,22955,6612,348995,672,7518,648,23279,6015	PHC2,HERC2,STAG1,NSMCE1,NSMCE2,SCMH1,SUMO3,NUP43,BRCA1,XRCC4,BMI1,NUP160,RING1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.000869293837528953	-7.04782935690823	212	25	0.0508130081300813	492	8202	3992,80205,5468,5095,27242,133522,56895,84803,23389,1374,253558,51129,788,123,57761,6721,51,9663,51586,26027,4199,6907,79888,6576,3156	FADS1,CHD9,PPARG,PCCA,TNFRSF21,PPARGC1B,AGPAT4,GPAT3,MED13L,CPT1A,LCLAT1,ANGPTL4,SLC25A20,PLIN2,TRIB3,SREBF2,ACOX1,LPIN2,MED15,ACOT11,ME1,TBL1X,LPCAT1,SLC25A1,HMGCR
R-HSA-1989781	PPARA activates gene expression	0.000989320365450151	-6.91849235012965	112	16	0.032520325203252	492	8202	3992,80205,5468,27242,133522,23389,1374,51129,123,57761,6721,51,51586,4199,6907,3156	FADS1,CHD9,PPARG,TNFRSF21,PPARGC1B,MED13L,CPT1A,ANGPTL4,PLIN2,TRIB3,SREBF2,ACOX1,MED15,ME1,TBL1X,HMGCR
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.00131906359140305	-6.63083319457966	115	16	0.032520325203252	492	8202	3992,80205,5468,27242,133522,23389,1374,51129,123,57761,6721,51,51586,4199,6907,3156	FADS1,CHD9,PPARG,TNFRSF21,PPARGC1B,MED13L,CPT1A,ANGPTL4,PLIN2,TRIB3,SREBF2,ACOX1,MED15,ME1,TBL1X,HMGCR
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.0019185092543198	-6.25620682456213	48	9	0.0182926829268293	492	8202	57459,2967,10919,1107,25885,2965,84172,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E
R-HSA-426048	Arachidonate production from DAG	0.00195864208186803	-6.23550386122064	5	3	0.00609756097560976	492	8202	221955,11343,57406	DAGLB,MGLL,ABHD6
R-HSA-418457	cGMP effects	0.00339350796743054	-5.68589109397275	18	5	0.0101626016260163	492	8202	5138,5140,10846,5152,5139	PDE2A,PDE3B,PDE10A,PDE9A,PDE3A
R-HSA-162587	HIV Life Cycle	0.00414712723173617	-5.48533941776022	140	17	0.0345528455284553	492	8202	27243,2967,6872,8731,6924,348995,6829,23279,51616,6827,3836,83860,79720,2965,22916,7518,92421	CHMP2A,GTF2H3,TAF1,RNMT,TCEB3,NUP43,SUPT5H,NUP160,TAF9B,SUPT4H1,KPNA1,TAF3,VPS37B,GTF2H1,NCBP2,XRCC4,CHMP4C
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.00442128489812592	-5.42132492420439	54	9	0.0182926829268293	492	8202	80205,3422,6721,3638,9871,6713,6907,1717,3156	CHD9,IDI1,SREBF2,INSIG1,SEC24D,SQLE,TBL1X,DHCR7,HMGCR
R-HSA-167172	Transcription of the HIV genome	0.0062198238220244	-5.08001369706557	67	10	0.0203252032520325	492	8202	2967,6827,6872,83860,8731,6924,2965,22916,6829,51616	GTF2H3,SUPT4H1,TAF1,TAF3,RNMT,TCEB3,GTF2H1,NCBP2,SUPT5H,TAF9B
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.0069434182631025	-4.96996108060832	21	5	0.0101626016260163	492	8202	2254,4893,6464,2247,2260	FGF9,NRAS,SHC1,FGF2,FGFR1
R-HSA-74160	Gene Expression	0.00755198354963266	-4.88594502842088	1330	100	0.203252032520325	492	8202	9534,51123,25885,348995,5578,85456,23279,16,10556,7586,93587,8565,7551,10794,30834,55534,8819,27339,79731,80205,7678,2617,7748,340252,5468,8731,2649,3035,147657,6924,4774,5451,29115,1207,7453,51616,25929,4088,6498,2744,6827,1107,28996,80818,2521,8891,80746,27327,833,348180,6872,4092,10946,10667,9887,677,10644,6748,5073,10643,54541,93134,54807,83860,54482,91801,2965,23438,26019,84172,374655,26986,5464,64425,10302,57459,171392,2967,10780,55253,57677,5682,4141,6829,6897,7025,3304,10940,7562,2058,10919,6158,6730,51586,6834,54901,80264,22916,6907,6727	ZNF254,ZNF706,POLR1A,NUP43,PRKCA,TNKS1BP1,NUP160,AARS,RPP30,ZKSCAN1,TRMT10A,YARS,ZNF3,ZNF460,ZNRD1,MAML3,SAP30,PRPF19,NARS2,CHD9,ZNF124,GARS,ZNF195,ZNF680,PPARG,RNMT,NR6A1,HARS,ZNF480,TCEB3,NFIA,POU2F1,SAP30BP,CLNS1A,WARS,TAF9B,GEMIN5,SMAD3,SKIL,GLS,SUPT4H1,CHD3,HIPK2,ZNF436,FUS,EIF2B3,TSEN2,TNRC6A,CARS,CTU2,TAF1,SMAD7,SF3A3,FARS2,SMG7,ZFP36L1,IGF2BP2,SSR4,PARN,IGF2BP3,DDIT4,ZNF561,ZNF586,TAF3,TRMT13,ALKBH8,GTF2H1,HARS2,UPF2,POLR1B,ZNF710,PABPC1,PPA1,POLR1E,SNAPC5,GATAD2B,ZNF675,GTF2H3,ZNF234,TYW1,ZFP14,PSMA1,MARS,SUPT5H,TARS,NR2F1,HSPA1B,POP1,ZNF708,EPRS,EHMT2,RPL28,SRP68,MED15,SURF1,CDKAL1,ZNF430,NCBP2,TBL1X,SRP14
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.00770590777501885	-4.8657680007944	39	7	0.0142276422764228	492	8202	54901,348180,2058,93587,54482,55253,91801	CDKAL1,CTU2,EPRS,TRMT10A,TRMT13,TYW1,ALKBH8
R-HSA-162599	Late Phase of HIV Life Cycle	0.00882535453639031	-4.73012650287451	127	15	0.0304878048780488	492	8202	27243,2967,6827,6872,83860,8731,79720,6924,2965,22916,348995,6829,23279,51616,92421	CHMP2A,GTF2H3,SUPT4H1,TAF1,TAF3,RNMT,VPS37B,TCEB3,GTF2H1,NCBP2,NUP43,SUPT5H,NUP160,TAF9B,CHMP4C
R-HSA-352230	Amino acid transport across the plasma membrane	0.00920781065826108	-4.68770317051712	31	6	0.0121951219512195	492	8202	6541,6520,23657,81539,54407,8501	SLC7A1,SLC3A2,SLC7A11,SLC38A1,SLC38A2,SLC43A1
R-HSA-73772	RNA Polymerase I Promoter Escape	0.00920781065826108	-4.68770317051712	31	6	0.0121951219512195	492	8202	2965,2967,84172,30834,64425,25885	GTF2H1,GTF2H3,POLR1B,ZNRD1,POLR1E,POLR1A
R-HSA-15869	Metabolism of nucleotides	0.00944824088253133	-4.66192670480123	82	11	0.0223577235772358	492	8202	847,3251,2618,204,7378,471,353,30833,3615,132,4907	CAT,HPRT1,GART,AK2,UPP1,ATIC,APRT,NT5C,IMPDH2,ADK,NT5E
R-HSA-72306	tRNA processing	0.0101214079233288	-4.59310250194092	94	12	0.024390243902439	492	8202	10556,10940,348180,2058,54482,55253,91801,54901,348995,80746,93587,23279	RPP30,POP1,CTU2,EPRS,TRMT13,TYW1,ALKBH8,CDKAL1,NUP43,TSEN2,TRMT10A,NUP160
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.0101598573023349	-4.58931088197621	41	7	0.0142276422764228	492	8202	6713,80205,6907,3422,6721,1717,3156	SQLE,CHD9,TBL1X,IDI1,SREBF2,DHCR7,HMGCR
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.0103448943322083	-4.57126218221976	3	2	0.0040650406504065	492	8202	10644,10643	IGF2BP2,IGF2BP3
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.0103998639535972	-4.56596255430525	23	5	0.0101626016260163	492	8202	2744,440,5832,29968,5831	GLS,ASNS,ALDH18A1,PSAT1,PYCR1
R-HSA-73863	RNA Polymerase I Transcription Termination	0.0107733821779436	-4.53067680016386	32	6	0.0121951219512195	492	8202	2965,2967,84172,30834,64425,25885	GTF2H1,GTF2H3,POLR1B,ZNRD1,POLR1E,POLR1A
R-HSA-400253	Circadian Clock	0.0122256462665744	-4.404219380677	63	9	0.0182926829268293	492	8202	56938,80205,4209,6907,8553,8204,1374,25819,4208	ARNTL2,CHD9,MEF2D,TBL1X,BHLHE40,NRIP1,CPT1A,NOCT,MEF2C
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.012504160534965	-4.38169384725656	24	5	0.0101626016260163	492	8202	5138,5140,10846,5152,5139	PDE2A,PDE3B,PDE10A,PDE9A,PDE3A
R-HSA-69190	DNA strand elongation	0.0125184986828601	-4.38054783400996	33	6	0.0121951219512195	492	8202	5984,4175,5983,328,4171,4174	RFC4,MCM6,RFC3,APEX1,MCM2,MCM5
R-HSA-4839726	Chromatin organization	0.0134358786090788	-4.30982664202441	261	25	0.0508130081300813	492	8202	23135,51780,57459,57634,10765,55904,63976,1019,84159,79813,58508,57492,317772,23028,10919,284058,23587,1107,6907,8242,4297,55689,23081,7994,8819	KDM6B,KDM3B,GATAD2B,EP400,KDM5B,KMT2E,PRDM16,CDK4,ARID5B,EHMT1,KMT2C,ARID1B,HIST2H2AB,KDM1A,EHMT2,KANSL1,ELP5,CHD3,TBL1X,KDM5C,KMT2A,YEATS2,KDM4C,KAT6A,SAP30
R-HSA-3247509	Chromatin modifying enzymes	0.0134358786090788	-4.30982664202441	261	25	0.0508130081300813	492	8202	23135,51780,57459,57634,10765,55904,63976,1019,84159,79813,58508,57492,317772,23028,10919,284058,23587,1107,6907,8242,4297,55689,23081,7994,8819	KDM6B,KDM3B,GATAD2B,EP400,KDM5B,KMT2E,PRDM16,CDK4,ARID5B,EHMT1,KMT2C,ARID1B,HIST2H2AB,KDM1A,EHMT2,KANSL1,ELP5,CHD3,TBL1X,KDM5C,KMT2A,YEATS2,KDM4C,KAT6A,SAP30
R-HSA-446107	Type I hemidesmosome assembly	0.013728137860861	-4.28830769397482	9	3	0.00609756097560976	492	8202	667,1308,3691	DST,COL17A1,ITGB4
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.0148625025153805	-4.20891384772182	65	9	0.0182926829268293	492	8202	2967,6827,6872,83860,6924,2965,22916,6829,51616	GTF2H3,SUPT4H1,TAF1,TAF3,TCEB3,GTF2H1,NCBP2,SUPT5H,TAF9B
R-HSA-380994	ATF4 activates genes	0.0148789433686549	-4.20780826226958	25	5	0.0101626016260163	492	8202	440,468,5073,9709,1649	ASNS,ATF4,PARN,HERPUD1,DDIT3
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0150728950707008	-4.19485717658574	628	51	0.103658536585366	492	8202	1591,2678,9871,27242,133522,84803,23389,81579,10162,79642,8867,253558,5305,788,3422,6721,9663,26027,4199,8871,79888,11343,5567,6576,3156,3992,80205,5468,5095,56895,56261,6916,10087,23760,1374,51129,80270,4758,123,57761,3638,51,51586,6713,8714,1800,6907,949,1717,8776,57107	CYP24A1,GGT1,SEC24D,TNFRSF21,PPARGC1B,GPAT3,MED13L,PLA2G12A,LPCAT3,ARSJ,SYNJ1,LCLAT1,PIP4K2A,SLC25A20,IDI1,SREBF2,LPIN2,ACOT11,ME1,SYNJ2,LPCAT1,MGLL,PRKACB,SLC25A1,HMGCR,FADS1,CHD9,PPARG,PCCA,AGPAT4,GPCPD1,TBXAS1,COL4A3BP,PITPNB,CPT1A,ANGPTL4,HSD3B7,NEU1,PLIN2,TRIB3,INSIG1,ACOX1,MED15,SQLE,ABCC3,DPEP1,TBL1X,SCARB1,DHCR7,MTMR1,PDSS2
R-HSA-2142845	Hyaluronan metabolism	0.0162852675446857	-4.11749441148587	17	4	0.00813008130081301	492	8202	3373,960,3038,57214	HYAL1,CD44,HAS3,CEMIP
R-HSA-189445	Metabolism of porphyrins	0.0162852675446857	-4.11749441148587	17	4	0.00813008130081301	492	8202	210,3163,1352,7389	ALAD,HMOX2,COX10,UROD
R-HSA-2559583	Cellular Senescence	0.0165905420089285	-4.09892250449197	187	19	0.0386178861788618	492	8202	23135,8091,57634,23043,3397,1019,79813,22955,6015,5606,7324,1912,54386,10919,10393,472,648,1021,27327	KDM6B,HMGA2,EP400,TNIK,ID1,CDK4,EHMT1,SCMH1,RING1,MAP2K3,UBE2E1,PHC2,TERF2IP,EHMT2,ANAPC10,ATM,BMI1,CDK6,TNRC6A
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.01753769002578	-4.04340299821497	26	5	0.0101626016260163	492	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-74259	Purine catabolism	0.0187507379430243	-3.97652217037888	10	3	0.00609756097560976	492	8202	847,30833,4907	CAT,NT5C,NT5E
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.0198697621560293	-3.91855619249361	4	2	0.0040650406504065	492	8202	10973,51008	ASCC3,ASCC1
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.0199686274234895	-3.91359286583997	18	4	0.00813008130081301	492	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-1430728	Metabolism	0.020355431728251	-3.89440748731594	1691	120	0.24390243902439	492	8202	6723,1591,2678,8802,27242,133522,57214,113278,7389,10162,348995,79642,5578,6535,3163,1352,8867,23279,253558,57019,80308,3422,440,6721,9663,3373,2941,4199,30833,2395,11343,2787,5567,80205,5468,7378,56261,10087,23760,25902,4953,4257,80270,51660,27010,2770,5831,123,54331,2744,3251,210,3638,3141,8714,949,9942,115677,204,50515,6819,9871,84803,5646,23389,8604,81579,353,3628,5305,788,2618,3038,783,471,26027,6472,8871,5106,5832,960,79888,5631,6576,4522,3156,4907,3992,29968,10243,5095,56895,11069,6916,5682,3615,23236,1374,51129,4758,5226,847,57761,2110,1462,51,51586,3099,6834,6566,6713,1800,6907,4725,1717,132,8776,57107,5576,9653	SRM,CYP24A1,GGT1,SUCLG1,TNFRSF21,PPARGC1B,CEMIP,SLC52A3,UROD,LPCAT3,NUP43,ARSJ,PRKCA,SLC6A8,HMOX2,COX10,SYNJ1,NUP160,LCLAT1,CIAPIN1,FLAD1,IDI1,ASNS,SREBF2,LPIN2,HYAL1,GSTA4,ME1,NT5C,FXN,MGLL,GNG5,PRKACB,CHD9,PPARG,UPP1,GPCPD1,COL4A3BP,PITPNB,MTHFD1L,ODC1,MGST1,HSD3B7,MPC1,TPK1,GNAI1,PYCR1,PLIN2,GNG2,GLS,HPRT1,ALAD,INSIG1,HLCS,ABCC3,SCARB1,XYLB,NOSTRIN,AK2,CHST11,SULT1C2,SEC24D,GPAT3,PRSS3,MED13L,SLC25A12,PLA2G12A,APRT,INPP1,PIP4K2A,SLC25A20,GART,HAS3,CACNB2,ATIC,ACOT11,SHMT2,SYNJ2,PCK2,ALDH18A1,CD44,LPCAT1,PRPS1,SLC25A1,MTHFD1,HMGCR,NT5E,FADS1,PSAT1,GPHN,PCCA,AGPAT4,RAPGEF4,TBXAS1,PSMA1,IMPDH2,PLCB1,CPT1A,ANGPTL4,NEU1,PGD,CAT,TRIB3,ETFDH,VCAN,ACOX1,MED15,HK2,SURF1,SLC16A1,SQLE,DPEP1,TBL1X,NDUFS5,DHCR7,ADK,MTMR1,PDSS2,PRKAR2A,HS2ST1
R-HSA-180024	DARPP-32 events	0.0204926840169082	-3.8876873337576	27	5	0.0101626016260163	492	8202	5533,5141,5576,5567,5142	PPP3CC,PDE4A,PRKAR2A,PRKACB,PDE4B
R-HSA-176187	Activation of ATR in response to replication stress	0.0214822936880895	-3.84052623254281	37	6	0.0121951219512195	492	8202	5984,4175,5983,55388,4171,4174	RFC4,MCM6,RFC3,MCM10,MCM2,MCM5
R-HSA-3214842	HDMs demethylate histones	0.023236701850152	-3.76202227401658	48	7	0.0142276422764228	492	8202	23135,51780,8242,10765,23028,84159,23081	KDM6B,KDM3B,KDM5C,KDM5B,KDM1A,ARID5B,KDM4C
R-HSA-381042	PERK regulates gene expression	0.0237549408060812	-3.73996473619729	28	5	0.0101626016260163	492	8202	440,468,5073,9709,1649	ASNS,ATF4,PARN,HERPUD1,DDIT3
R-HSA-1483166	Synthesis of PA	0.0237549408060812	-3.73996473619729	28	5	0.0101626016260163	492	8202	81579,79888,253558,56895,84803	PLA2G12A,LPCAT1,LCLAT1,AGPAT4,GPAT3
R-HSA-109582	Hemostasis	0.0245660915268482	-3.70638818011918	515	42	0.0853658536585366	492	8202	7273,2335,3798,11311,5578,57406,5139,23028,5583,10019,6464,6281,23657,10846,960,3273,7414,11343,2787,5567,285,3048,4893,6520,11069,56992,5908,5138,5140,7114,1525,2770,54331,2627,221955,3673,2734,5890,6566,1191,5152,5576	TTN,FN1,KIF5A,VPS45,PRKCA,ABHD6,PDE3A,KDM1A,PRKCH,SH2B3,SHC1,S100A10,SLC7A11,PDE10A,CD44,HRG,VCL,MGLL,GNG5,PRKACB,ANGPT2,HBG2,NRAS,SLC3A2,RAPGEF4,KIF15,RAP1B,PDE2A,PDE3B,TMSB4X,CXADR,GNAI1,GNG2,GATA6,DAGLB,ITGA2,GLG1,RAD51B,SLC16A1,CLU,PDE9A,PRKAR2A
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.0246542243370872	-3.70280702047476	11	3	0.00609756097560976	492	8202	3615,2618,471	IMPDH2,GART,ATIC
R-HSA-196757	Metabolism of folate and pterines	0.0246542243370872	-3.70280702047476	11	3	0.00609756097560976	492	8202	6472,25902,4522	SHMT2,MTHFD1L,MTHFD1
R-HSA-189451	Heme biosynthesis	0.0246542243370872	-3.70280702047476	11	3	0.00609756097560976	492	8202	210,1352,7389	ALAD,COX10,UROD
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0246542243370872	-3.70280702047476	11	3	0.00609756097560976	492	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0272720301057851	-3.60189364023892	39	6	0.0121951219512195	492	8202	472,5984,672,5983,5890,7156	ATM,RFC4,BRCA1,RFC3,RAD51B,TOP3A
R-HSA-111885	Opioid Signalling	0.0280890004205729	-3.57237722338441	84	10	0.0203252032520325	492	8202	54331,5141,5142,5533,5578,23236,2787,5576,5567,2770	GNG2,PDE4A,PDE4B,PPP3CC,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-3000170	Syndecan interactions	0.0287665583279813	-3.5485417356868	20	4	0.00813008130081301	492	8202	3691,5578,2247,3673	ITGB4,PRKCA,FGF2,ITGA2
R-HSA-373760	L1CAM interactions	0.0301405210142361	-3.50188479946219	97	11	0.0223577235772358	492	8202	26052,3786,287,3673,1742,5962,23114,8829,9252,2260,6709	DNM3,KCNQ3,ANK2,ITGA2,DLG4,RDX,NFASC,NRP1,RPS6KA5,FGFR1,SPTAN1
R-HSA-5696400	Dual Incision in GG-NER	0.0305193034073546	-3.48939589696284	40	6	0.0121951219512195	492	8202	2965,2967,5984,5983,51426,10038	GTF2H1,GTF2H3,RFC4,RFC3,POLK,PARP2
R-HSA-72086	mRNA Capping	0.0312386384433187	-3.46609953872106	30	5	0.0101626016260163	492	8202	2965,2967,22916,6829,8731	GTF2H1,GTF2H3,NCBP2,SUPT5H,RNMT
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.031438841251676	-3.45971116796305	12	3	0.00609756097560976	492	8202	7431,4137,6709	VIM,MAPT,SPTAN1
R-HSA-190373	FGFR1c ligand binding and activation	0.031438841251676	-3.45971116796305	12	3	0.00609756097560976	492	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-73621	Pyrimidine catabolism	0.031438841251676	-3.45971116796305	12	3	0.00609756097560976	492	8202	30833,7378,4907	NT5C,UPP1,NT5E
R-HSA-176974	Unwinding of DNA	0.031438841251676	-3.45971116796305	12	3	0.00609756097560976	492	8202	4175,4171,4174	MCM6,MCM2,MCM5
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.0318105088721493	-3.44795857611077	5	2	0.0040650406504065	492	8202	10973,51008	ASCC3,ASCC1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0318105088721493	-3.44795857611077	5	2	0.0040650406504065	492	8202	3038,57214	HAS3,CEMIP
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.0318105088721493	-3.44795857611077	5	2	0.0040650406504065	492	8202	80308,113278	FLAD1,SLC52A3
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.0339014148146802	-3.38429853052029	21	4	0.00813008130081301	492	8202	10667,79731,23438,2617	FARS2,NARS2,HARS2,GARS
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0377477199359853	-3.27683020415795	42	6	0.0121951219512195	492	8202	3910,3691,5578,2247,3911,3673	LAMA4,ITGB4,PRKCA,FGF2,LAMA5,ITGA2
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.0377477199359853	-3.27683020415795	42	6	0.0121951219512195	492	8202	472,5984,672,5983,5890,7156	ATM,RFC4,BRCA1,RFC3,RAD51B,TOP3A
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0377477199359853	-3.27683020415795	42	6	0.0121951219512195	492	8202	56938,80205,6907,8553,8204,25819	ARNTL2,CHD9,TBL1X,BHLHE40,NRIP1,NOCT
R-HSA-74217	Purine salvage	0.0390942749297194	-3.24177924394625	13	3	0.00609756097560976	492	8202	353,3251,132	APRT,HPRT1,ADK
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.0395347350404061	-3.23057562538113	22	4	0.00813008130081301	492	8202	5984,5983,328,10038	RFC4,RFC3,APEX1,PARP2
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.0400497720044145	-3.21763229825764	32	5	0.0101626016260163	492	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.0417383799477531	-3.17633419102947	43	6	0.0121951219512195	492	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.0417383799477531	-3.17633419102947	43	6	0.0121951219512195	492	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-167169	HIV Transcription Elongation	0.0417383799477531	-3.17633419102947	43	6	0.0121951219512195	492	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-196854	Metabolism of vitamins and cofactors	0.0424482157365588	-3.15947039922691	90	10	0.0203252032520325	492	8202	80308,10243,3141,5095,113278,5646,6472,25902,27010,4522	FLAD1,GPHN,HLCS,PCCA,SLC52A3,PRSS3,SHMT2,MTHFD1L,TPK1,MTHFD1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.0424482157365588	-3.15947039922691	90	10	0.0203252032520325	492	8202	80308,10243,3141,5095,113278,5646,6472,25902,27010,4522	FLAD1,GPHN,HLCS,PCCA,SLC52A3,PRSS3,SHMT2,MTHFD1L,TPK1,MTHFD1
R-HSA-162906	HIV Infection	0.0425099715785166	-3.15801660519513	221	20	0.040650406504065	492	8202	27243,2967,6872,8731,6924,5682,348995,162,6829,23279,51616,6827,3836,83860,79720,8907,2965,22916,7518,92421	CHMP2A,GTF2H3,TAF1,RNMT,TCEB3,PSMA1,NUP43,AP1B1,SUPT5H,NUP160,TAF9B,SUPT4H1,KPNA1,TAF3,VPS37B,AP1M1,GTF2H1,NCBP2,XRCC4,CHMP4C
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.0429676760504818	-3.14730716572778	78	9	0.0182926829268293	492	8202	80205,6721,5468,1019,51586,23389,6907,7026,51129	CHD9,SREBF2,PPARG,CDK4,MED15,MED13L,TBL1X,NR2F2,ANGPTL4
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.0456683921110842	-3.0863488590815	23	4	0.00813008130081301	492	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-3000157	Laminin interactions	0.0456683921110842	-3.0863488590815	23	4	0.00813008130081301	492	8202	3910,3691,3911,3673	LAMA4,ITGB4,LAMA5,ITGA2
R-HSA-191273	Cholesterol biosynthesis	0.0456683921110842	-3.0863488590815	23	4	0.00813008130081301	492	8202	6713,3422,1717,3156	SQLE,IDI1,DHCR7,HMGCR
R-HSA-190370	FGFR1b ligand binding and activation	0.0458442003050556	-3.08250658108196	6	2	0.0040650406504065	492	8202	2247,2260	FGF2,FGFR1
R-HSA-73942	DNA Damage Reversal	0.0458442003050556	-3.08250658108196	6	2	0.0040650406504065	492	8202	10973,51008	ASCC3,ASCC1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0458442003050556	-3.08250658108196	6	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.0459851412691302	-3.07943695056239	44	6	0.0121951219512195	492	8202	2965,22916,2967,6827,6829,6924	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H,TCEB3
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.0459851412691302	-3.07943695056239	44	6	0.0121951219512195	492	8202	2965,2967,22916,6827,6829,6924	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H,TCEB3
R-HSA-112382	Formation of RNA Pol II elongation complex	0.0459851412691302	-3.07943695056239	44	6	0.0121951219512195	492	8202	2965,2967,22916,6827,6829,6924	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H,TCEB3
R-HSA-177929	Signaling by EGFR	0.0473400178707021	-3.05039929739949	336	28	0.0569105691056911	492	8202	2254,200734,5829,673,4893,8831,2335,2308,2247,5786,58513,5908,5682,1742,5578,55824,2260,3667,57761,817,6464,7414,5576,5567,27327,6709,6199,5796	FGF9,SPRED2,PXN,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,EPS15L1,RAP1B,PSMA1,DLG4,PRKCA,PAG1,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,SPTAN1,RPS6KB2,PTPRK
R-HSA-877312	Regulation of IFNG signaling	0.0476013510647493	-3.04489413443435	14	3	0.00609756097560976	492	8202	5771,8651,3460	PTPN2,SOCS1,IFNGR2
R-HSA-422356	Regulation of insulin secretion	0.0492509462705356	-3.01082669793368	80	9	0.0182926829268293	492	8202	54331,783,11069,5578,23236,2787,5576,5567,2770	GNG2,CACNB2,RAPGEF4,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-113418	Formation of the Early Elongation Complex	0.0502269656396225	-2.99120323236956	34	5	0.0101626016260163	492	8202	2965,2967,22916,6827,6829	GTF2H1,GTF2H3,NCBP2,SUPT4H1,SUPT5H
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.0502269656396225	-2.99120323236956	34	5	0.0101626016260163	492	8202	2965,22916,2967,6827,6829	GTF2H1,NCBP2,GTF2H3,SUPT4H1,SUPT5H
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0523012384261375	-2.95073522891556	24	4	0.00813008130081301	492	8202	2744,6857,10550,54407	GLS,SYT1,ARL6IP5,SLC38A2
R-HSA-1483257	Phospholipid metabolism	0.054816252673878	-2.9037685473597	146	14	0.0284552845528455	492	8202	56895,84803,56261,9663,81579,10162,23760,8871,79888,253558,11343,8776,8867,5305	AGPAT4,GPAT3,GPCPD1,LPIN2,PLA2G12A,LPCAT3,PITPNB,SYNJ2,LPCAT1,LCLAT1,MGLL,MTMR1,SYNJ1,PIP4K2A
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.0558338205523052	-2.88537549011326	35	5	0.0101626016260163	492	8202	5984,5983,328,10038,4595	RFC4,RFC3,APEX1,PARP2,MUTYH
R-HSA-73884	Base Excision Repair	0.0558338205523052	-2.88537549011326	35	5	0.0101626016260163	492	8202	5984,5983,328,10038,4595	RFC4,RFC3,APEX1,PARP2,MUTYH
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.0569335415496966	-2.86587062910639	15	3	0.00609756097560976	492	8202	5578,9663,7112	PRKCA,LPIN2,TMPO
R-HSA-425410	Metal ion SLC transporters	0.059429294629002	-2.82296799861222	25	4	0.00813008130081301	492	8202	23516,30061,7922,148867	SLC39A14,SLC40A1,SLC39A7,SLC30A7
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.0599853694212871	-2.81365458947312	1	1	0.00203252032520325	492	8202	2260	FGFR1
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.0599853694212871	-2.81365458947312	1	1	0.00203252032520325	492	8202	23760	PITPNB
R-HSA-1483206	Glycerophospholipid biosynthesis	0.0611489300925493	-2.79444291344439	96	10	0.0203252032520325	492	8202	56895,84803,56261,9663,10162,81579,23760,253558,11343,79888	AGPAT4,GPAT3,GPCPD1,LPIN2,LPCAT3,PLA2G12A,PITPNB,LCLAT1,MGLL,LPCAT1
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0616778205371735	-2.78583088535179	7	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0616778205371735	-2.78583088535179	7	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.0616778205371735	-2.78583088535179	7	2	0.0040650406504065	492	8202	328,10038	APEX1,PARP2
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.0616778205371735	-2.78583088535179	7	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0616778205371735	-2.78583088535179	7	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-5655302	Signaling by FGFR1 in disease	0.0617866622406361	-2.7840677591602	36	5	0.0101626016260163	492	8202	2254,4893,2247,2260,1523	FGF9,NRAS,FGF2,FGFR1,CUX1
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.0670459500112241	-2.70237707359592	26	4	0.00813008130081301	492	8202	472,672,5890,7156	ATM,BRCA1,RAD51B,TOP3A
R-HSA-264876	Insulin processing	0.0670459500112241	-2.70237707359592	26	4	0.00813008130081301	492	8202	3800,3798,60412,148867	KIF5C,KIF5A,EXOC4,SLC30A7
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.0670459500112241	-2.70237707359592	26	4	0.00813008130081301	492	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-1433559	Regulation of KIT signaling	0.0670582987662467	-2.70219290709605	16	3	0.00609756097560976	492	8202	10019,8651,5578	SH2B3,SOCS1,PRKCA
R-HSA-392517	Rap1 signalling	0.0670582987662467	-2.70219290709605	16	3	0.00609756097560976	492	8202	5567,11069,5908	PRKACB,RAPGEF4,RAP1B
R-HSA-190242	FGFR1 ligand binding and activation	0.0670582987662467	-2.70219290709605	16	3	0.00609756097560976	492	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.0680842198283833	-2.68700981325977	37	5	0.0101626016260163	492	8202	472,5984,672,5983,7156	ATM,RFC4,BRCA1,RFC3,TOP3A
R-HSA-2262752	Cellular responses to stress	0.0711080493366909	-2.64355473709437	379	30	0.0609756097560976	492	8202	23135,8091,57634,27243,23043,3397,9588,1019,475,79813,9140,22955,348995,23279,6015,5606,7324,3304,1912,54386,847,817,10919,10393,472,648,1021,573,27327,92421	KDM6B,HMGA2,EP400,CHMP2A,TNIK,ID1,PRDX6,CDK4,ATOX1,EHMT1,ATG12,SCMH1,NUP43,NUP160,RING1,MAP2K3,UBE2E1,HSPA1B,PHC2,TERF2IP,CAT,CAMK2D,EHMT2,ANAPC10,ATM,BMI1,CDK6,BAG1,TNRC6A,CHMP4C
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.0711368332484735	-2.643150027812	49	6	0.0121951219512195	492	8202	2254,5578,2247,5576,2260,5567	FGF9,PRKCA,FGF2,PRKAR2A,FGFR1,PRKACB
R-HSA-4086398	Ca2+ pathway	0.0712822386420375	-2.64110808999909	61	7	0.0142276422764228	492	8202	54331,5578,23236,2787,7976,6934,27327	GNG2,PRKCA,PLCB1,GNG5,FZD3,TCF7L2,TNRC6A
R-HSA-202733	Cell surface interactions at the vascular wall	0.0722349106025792	-2.62783182359304	99	10	0.0203252032520325	492	8202	6520,4893,2335,6464,23657,2734,6566,960,285,1525	SLC3A2,NRAS,FN1,SHC1,SLC7A11,GLG1,SLC16A1,CD44,ANGPT2,CXADR
R-HSA-5674135	MAP2K and MAPK activation	0.0747239717050946	-2.59395433196276	38	5	0.0101626016260163	492	8202	673,4893,2335,7414,5908	BRAF,NRAS,FN1,VCL,RAP1B
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.0751421701834717	-2.58837335738658	27	4	0.00813008130081301	492	8202	2335,6464,11069,5908	FN1,SHC1,RAPGEF4,RAP1B
R-HSA-114508	Effects of PIP2 hydrolysis	0.0751421701834717	-2.58837335738658	27	4	0.00813008130081301	492	8202	5583,221955,11343,57406	PRKCH,DAGLB,MGLL,ABHD6
R-HSA-1368082	RORA activates gene expression	0.0751421701834717	-2.58837335738658	27	4	0.00813008130081301	492	8202	80205,6907,8204,1374	CHD9,TBL1X,NRIP1,CPT1A
R-HSA-2980766	Nuclear Envelope Breakdown	0.076955666661091	-2.5645257805887	50	6	0.0121951219512195	492	8202	348995,10783,5578,23279,9663,7112	NUP43,NEK6,PRKCA,NUP160,LPIN2,TMPO
R-HSA-5655862	Translesion synthesis by POLK	0.0779382340293188	-2.55183863740732	17	3	0.00609756097560976	492	8202	5984,5983,51426	RFC4,RFC3,POLK
R-HSA-435354	Zinc transporters	0.0779382340293188	-2.55183863740732	17	3	0.00609756097560976	492	8202	23516,7922,148867	SLC39A14,SLC39A7,SLC30A7
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.0779382340293188	-2.55183863740732	17	3	0.00609756097560976	492	8202	7187,9020,329	TRAF3,MAP3K14,BIRC2
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.0790458560700956	-2.53772713833139	8	2	0.0040650406504065	492	8202	4088,7048	SMAD3,TGFBR2
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.0837067084139068	-2.48043615638411	28	4	0.00813008130081301	492	8202	54331,783,2787,2770	GNG2,CACNB2,GNG5,GNAI1
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.0837067084139068	-2.48043615638411	28	4	0.00813008130081301	492	8202	2965,2967,6829,8731	GTF2H1,GTF2H3,SUPT5H,RNMT
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.0837067084139068	-2.48043615638411	28	4	0.00813008130081301	492	8202	2965,2967,6829,8731	GTF2H1,GTF2H3,SUPT5H,RNMT
R-HSA-180292	GAB1 signalosome	0.084510407501653	-2.47088058650325	102	10	0.0203252032520325	492	8202	3667,57761,2254,5829,2308,2247,55824,2260,27327,6199	IRS1,TRIB3,FGF9,PXN,FOXO1,FGF2,PAG1,FGFR1,TNRC6A,RPS6KB2
R-HSA-2132295	MHC class II antigen presentation	0.084510407501653	-2.47088058650325	102	10	0.0203252032520325	492	8202	1778,26052,9871,3798,51164,56992,8907,79659,162,114876	DYNC1H1,DNM3,SEC24D,KIF5A,DCTN4,KIF15,AP1M1,DYNC2H1,AP1B1,OSBPL1A
R-HSA-210993	Tie2 Signaling	0.0895321553490232	-2.41315744058337	18	3	0.00609756097560976	492	8202	4893,6464,285	NRAS,SHC1,ANGPT2
R-HSA-375170	CDO in myogenesis	0.0927263176307863	-2.37810294561538	29	4	0.00813008130081301	492	8202	6938,4209,6929,4208	TCF12,MEF2D,TCF3,MEF2C
R-HSA-445095	Interaction between L1 and Ankyrins	0.0927263176307863	-2.37810294561538	29	4	0.00813008130081301	492	8202	23114,3786,287,6709	NFASC,KCNQ3,ANK2,SPTAN1
R-HSA-525793	Myogenesis	0.0927263176307863	-2.37810294561538	29	4	0.00813008130081301	492	8202	6938,4209,6929,4208	TCF12,MEF2D,TCF3,MEF2C
R-HSA-1839124	FGFR1 mutant receptor activation	0.0927263176307863	-2.37810294561538	29	4	0.00813008130081301	492	8202	2254,2247,2260,1523	FGF9,FGF2,FGFR1,CUX1
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.0931167606975372	-2.37390108192777	65	7	0.0142276422764228	492	8202	472,5984,672,5983,51426,5890,7156	ATM,RFC4,BRCA1,RFC3,POLK,RAD51B,TOP3A
R-HSA-5683057	MAPK family signaling cascades	0.0956886557525823	-2.34665552723005	273	22	0.0447154471544715	492	8202	2254,200734,673,4893,8831,10435,2335,2308,2247,5786,5908,5682,1742,3570,2260,3667,817,6464,7414,5567,27327,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,CDC42EP2,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-1266738	Developmental Biology	0.0975511948577907	-2.3273779633177	710	51	0.103658536585366	492	8202	1948,6938,200734,26052,673,2335,2308,71,5786,6929,7204,8912,23389,5087,55740,9252,57556,6464,6721,783,5962,7414,6709,2254,80205,4893,51466,8831,3786,2247,2649,5468,1019,287,5908,5682,1742,23365,4209,51129,2260,4088,3667,817,51586,3673,6907,23114,8829,7026,4208	EFNB2,TCF12,SPRED2,DNM3,BRAF,FN1,FOXO1,ACTG1,PTPRA,TCF3,TRIO,CACNA1H,MED13L,PBX1,ENAH,RPS6KA5,SEMA6A,SHC1,SREBF2,CACNB2,RDX,VCL,SPTAN1,FGF9,CHD9,NRAS,EVL,SYNGAP1,KCNQ3,FGF2,NR6A1,PPARG,CDK4,ANK2,RAP1B,PSMA1,DLG4,ARHGEF12,MEF2D,ANGPTL4,FGFR1,SMAD3,IRS1,CAMK2D,MED15,ITGA2,TBL1X,NFASC,NRP1,NR2F2,MEF2C
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	328,4595	APEX1,MUTYH
R-HSA-162592	Integration of provirus	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	3836,7518	KPNA1,XRCC4
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	4893,5578	NRAS,PRKCA
R-HSA-447041	CHL1 interactions	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	8829,3673	NRP1,ITGA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.0977080612734732	-2.32577121286153	9	2	0.0040650406504065	492	8202	2308,6199	FOXO1,RPS6KB2
R-HSA-69481	G2/M Checkpoints	0.0979829557201543	-2.32296173666053	105	10	0.0203252032520325	492	8202	8924,5984,4175,9577,5983,55388,4174,472,672,4171	HERC2,RFC4,MCM6,BRE,RFC3,MCM10,MCM5,ATM,BRCA1,MCM2
R-HSA-69618	Mitotic Spindle Checkpoint	0.101795978373352	-2.28478468081942	19	3	0.00609756097560976	492	8202	7324,10393,8379	UBE2E1,ANAPC10,MAD1L1
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.101795978373352	-2.28478468081942	19	3	0.00609756097560976	492	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-5656169	Termination of translesion DNA synthesis	0.102185960581584	-2.28096098264909	30	4	0.00813008130081301	492	8202	5984,5983,51426,9636	RFC4,RFC3,POLK,ISG15
R-HSA-68962	Activation of the pre-replicative complex	0.102185960581584	-2.28096098264909	30	4	0.00813008130081301	492	8202	4175,55388,4171,4174	MCM6,MCM10,MCM2,MCM5
R-HSA-2559585	Oncogene Induced Senescence	0.102185960581584	-2.28096098264909	30	4	0.00813008130081301	492	8202	3397,1021,1019,27327	ID1,CDK6,CDK4,TNRC6A
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.104613809660046	-2.25747971254704	42	5	0.0101626016260163	492	8202	80205,6907,4209,133522,4208	CHD9,TBL1X,MEF2D,PPARGC1B,MEF2C
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.104613809660046	-2.25747971254704	42	5	0.0101626016260163	492	8202	54331,5576,2787,5567,11069	GNG2,PRKAR2A,GNG5,PRKACB,RAPGEF4
R-HSA-73857	RNA Polymerase II Transcription	0.107627184139695	-2.22908202245925	107	10	0.0203252032520325	492	8202	2967,6827,8731,6872,83860,6924,2965,22916,6829,51616	GTF2H3,SUPT4H1,RNMT,TAF1,TAF3,TCEB3,GTF2H1,NCBP2,SUPT5H,TAF9B
R-HSA-1433557	Signaling by SCF-KIT	0.109154000571433	-2.21499554460625	307	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,10019,3667,57761,817,6464,8651,7414,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,SH2B3,IRS1,TRIB3,CAMK2D,SHC1,SOCS1,VCL,TNRC6A,SPTAN1,RPS6KB2
R-HSA-75109	Triglyceride Biosynthesis	0.111679201617296	-2.19212478883589	68	7	0.0142276422764228	492	8202	79888,253558,56895,84803,9663,6576,26027	LPCAT1,LCLAT1,AGPAT4,GPAT3,LPIN2,SLC25A1,ACOT11
R-HSA-70263	Gluconeogenesis	0.112069016060311	-2.18864038264523	31	4	0.00813008130081301	492	8202	8604,5106,5567,6576	SLC25A12,PCK2,PRKACB,SLC25A1
R-HSA-1643685	Disease	0.113923756419206	-2.17222585767666	657	47	0.0955284552845529	492	8202	27243,2308,6872,54894,348995,162,7048,23279,5606,182,6464,83860,8907,2965,6199,55534,2967,2254,4893,2247,8731,5095,6924,1523,5682,6829,6857,9636,2260,6934,3304,51616,22943,3667,4088,3836,6827,6158,1462,79720,22916,7187,6907,4793,7518,5947,92421	CHMP2A,FOXO1,TAF1,RNF43,NUP43,AP1B1,TGFBR2,NUP160,MAP2K3,JAG1,SHC1,TAF3,AP1M1,GTF2H1,RPS6KB2,MAML3,GTF2H3,FGF9,NRAS,FGF2,RNMT,PCCA,TCEB3,CUX1,PSMA1,SUPT5H,SYT1,ISG15,FGFR1,TCF7L2,HSPA1B,TAF9B,DKK1,IRS1,SMAD3,KPNA1,SUPT4H1,RPL28,VCAN,VPS37B,NCBP2,TRAF3,TBL1X,NFKBIB,XRCC4,RBP1,CHMP4C
R-HSA-2028269	Signaling by Hippo	0.114683523087312	-2.16557891741241	20	3	0.00609756097560976	492	8202	23286,154810,6789	WWC1,AMOTL1,STK4
R-HSA-418217	G beta:gamma signalling through PLC beta	0.114683523087312	-2.16557891741241	20	3	0.00609756097560976	492	8202	54331,23236,2787	GNG2,PLCB1,GNG5
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	3304	HSPA1B
R-HSA-141424	Amplification of signal from the kinetochores	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	8379	MAD1L1
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	7048	TGFBR2
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	8379	MAD1L1
R-HSA-165160	PDE3B signalling	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	5140	PDE3B
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.116379369936061	-2.15089999361892	2	1	0.00203252032520325	492	8202	328	APEX1
R-HSA-381183	ATF6-alpha activates chaperone genes	0.117447392105939	-2.14176477241544	10	2	0.0040650406504065	492	8202	468,1649	ATF4,DDIT3
R-HSA-74749	Signal attenuation	0.117447392105939	-2.14176477241544	10	2	0.0040650406504065	492	8202	3667,6464	IRS1,SHC1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.117447392105939	-2.14176477241544	10	2	0.0040650406504065	492	8202	23516,7922	SLC39A14,SLC39A7
R-HSA-399997	Acetylcholine regulates insulin secretion	0.117447392105939	-2.14176477241544	10	2	0.0040650406504065	492	8202	5578,23236	PRKCA,PLCB1
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.117447392105939	-2.14176477241544	10	2	0.0040650406504065	492	8202	162,8907	AP1B1,AP1M1
R-HSA-5654716	Downstream signaling of activated FGFR4	0.118026773459758	-2.1368437865262	310	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5654687	Downstream signaling of activated FGFR1	0.118026773459758	-2.1368437865262	310	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5654708	Downstream signaling of activated FGFR3	0.118026773459758	-2.1368437865262	310	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.118026773459758	-2.1368437865262	310	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.119102729307478	-2.12776888678373	355	27	0.0548780487804878	492	8202	2254,200734,26052,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,9252,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709,4208	FGF9,SPRED2,DNM3,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,RPS6KA5,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1,MEF2C
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.122357479497172	-2.10080835898669	32	4	0.00813008130081301	492	8202	1742,54331,23236,2787	DLG4,GNG2,PLCB1,GNG5
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.122357479497172	-2.10080835898669	32	4	0.00813008130081301	492	8202	2254,673,2247,2260	FGF9,BRAF,FGF2,FGFR1
R-HSA-194840	Rho GTPase cycle	0.124127041484385	-2.08644970974794	124	11	0.0223577235772358	492	8202	23092,58480,93663,7204,84033,94134,101928168,23365,9743,100288637,5881	ARHGAP26,RHOU,ARHGAP18,TRIO,OBSCN,ARHGAP12,LOC101928168,ARHGEF12,ARHGAP32,LOC100288637,RAC3
R-HSA-5654741	Signaling by FGFR3	0.127334620275089	-2.06093685222232	313	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5654743	Signaling by FGFR4	0.127334620275089	-2.06093685222232	313	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-500657	Presynaptic function of Kainate receptors	0.128147207804101	-2.0545756149065	21	3	0.00609756097560976	492	8202	54331,23236,2787	GNG2,PLCB1,GNG5
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.128147207804101	-2.0545756149065	21	3	0.00609756097560976	492	8202	4893,9252,5567	NRAS,RPS6KA5,PRKACB
R-HSA-69186	Lagging Strand Synthesis	0.128147207804101	-2.0545756149065	21	3	0.00609756097560976	492	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-1226099	Signaling by FGFR in disease	0.130335678890238	-2.03764201122652	45	5	0.0101626016260163	492	8202	2254,4893,2247,2260,1523	FGF9,NRAS,FGF2,FGFR1,CUX1
R-HSA-5654736	Signaling by FGFR1	0.130533652686253	-2.03612421047299	314	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.133032156557221	-2.0171644013584	33	4	0.00813008130081301	492	8202	472,672,5890,7156	ATM,BRCA1,RAD51B,TOP3A
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.133032156557221	-2.0171644013584	33	4	0.00813008130081301	492	8202	8871,8867,8776,5305	SYNJ2,SYNJ1,MTMR1,PIP4K2A
R-HSA-163359	Glucagon signaling in metabolic regulation	0.133032156557221	-2.0171644013584	33	4	0.00813008130081301	492	8202	54331,5576,2787,5567	GNG2,PRKAR2A,GNG5,PRKACB
R-HSA-5654738	Signaling by FGFR2	0.137075713267845	-1.98722185421955	316	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-196780	Biotin transport and metabolism	0.138068096055267	-1.98000826585534	11	2	0.0040650406504065	492	8202	3141,5095	HLCS,PCCA
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.138068096055267	-1.98000826585534	11	2	0.0040650406504065	492	8202	114799,10274	ESCO1,STAG1
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.138068096055267	-1.98000826585534	11	2	0.0040650406504065	492	8202	1374,788	CPT1A,SLC25A20
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.138068096055267	-1.98000826585534	11	2	0.0040650406504065	492	8202	8867,3628	SYNJ1,INPP1
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-73776	RNA Polymerase II Promoter Escape	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-112043	PLC beta mediated events	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	5578,23236,5576,5567,2770	PRKCA,PLCB1,PRKAR2A,PRKACB,GNAI1
R-HSA-167161	HIV Transcription Initiation	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-73893	DNA Damage Bypass	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	5984,5983,56852,51426,9636	RFC4,RFC3,RAD18,POLK,ISG15
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-418597	G alpha (z) signalling events	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	54331,5583,5578,2787,2770	GNG2,PRKCH,PRKCA,GNG5,GNAI1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.139491502329043	-1.96975159478012	46	5	0.0101626016260163	492	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-190236	Signaling by FGFR	0.140418456774457	-1.96312833752281	317	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5423646	Aflatoxin activation and detoxification	0.142138650867038	-1.95095228320689	22	3	0.00609756097560976	492	8202	2678,1800,4257	GGT1,DPEP1,MGST1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.142138650867038	-1.95095228320689	22	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-5655332	Signaling by FGFR3 in disease	0.142138650867038	-1.95095228320689	22	3	0.00609756097560976	492	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.142138650867038	-1.95095228320689	22	3	0.00609756097560976	492	8202	5947,157506,4647	RBP1,RDH10,MYO7A
R-HSA-5693537	Resolution of D-Loop Structures	0.144072848681507	-1.9374362137056	34	4	0.00813008130081301	492	8202	472,672,5890,7156	ATM,BRCA1,RAD51B,TOP3A
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.144072848681507	-1.9374362137056	34	4	0.00813008130081301	492	8202	9140,7187,3093,9636	ATG12,TRAF3,UBE2K,ISG15
R-HSA-112040	G-protein mediated events	0.148920542176783	-1.90434238925914	47	5	0.0101626016260163	492	8202	5578,23236,5576,5567,2770	PRKCA,PLCB1,PRKAR2A,PRKACB,GNAI1
R-HSA-1227986	Signaling by ERBB2	0.150731382285055	-1.89225595159832	320	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-429947	Deadenylation of mRNA	0.156609189682201	-1.85400181462993	23	3	0.00609756097560976	492	8202	85456,5073,26986	TNKS1BP1,PARN,PABPC1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.156609189682201	-1.85400181462993	23	3	0.00609756097560976	492	8202	5984,5983,51426	RFC4,RFC3,POLK
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.156609189682201	-1.85400181462993	23	3	0.00609756097560976	492	8202	22916,6827,6829	NCBP2,SUPT4H1,SUPT5H
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.156609189682201	-1.85400181462993	23	3	0.00609756097560976	492	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-186763	Downstream signal transduction	0.157841685633265	-1.84616273794527	322	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.158611239123339	-1.84129910770617	48	5	0.0101626016260163	492	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-2160916	Hyaluronan uptake and degradation	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	3373,960	HYAL1,CD44
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-190239	FGFR3 ligand binding and activation	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-381033	ATF6-alpha activates chaperones	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	468,1649	ATF4,DDIT3
R-HSA-190372	FGFR3c ligand binding and activation	0.159393947017428	-1.83637648688889	12	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.160288691456763	-1.83077876797638	145	12	0.024390243902439	492	8202	57459,2967,10919,1107,25885,4774,5451,2965,84172,30834,64425,10302	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,NFIA,POU2F1,GTF2H1,POLR1B,ZNRD1,POLR1E,SNAPC5
R-HSA-166520	Signalling by NGF	0.162591310972845	-1.81651552134767	430	31	0.0630081300813008	492	8202	2254,200734,26052,673,4893,8831,2335,2308,2247,5786,7204,5908,5682,1742,84033,57142,23365,5578,9252,2260,3667,57761,817,6464,7414,5576,5567,27327,6709,6199,4208	FGF9,SPRED2,DNM3,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,TRIO,RAP1B,PSMA1,DLG4,OBSCN,RTN4,ARHGEF12,PRKCA,RPS6KA5,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,SPTAN1,RPS6KB2,MEF2C
R-HSA-5684996	MAPK1/MAPK3 signaling	0.165590667120823	-1.79823639658519	234	18	0.0365853658536585	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,3570,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-2424491	DAP12 signaling	0.168854260172683	-1.77871930195251	325	24	0.0487804878048781	492	8202	2254,200734,673,4893,2335,8831,2308,2247,5786,5908,5682,1742,5578,2260,3667,817,57761,6464,7414,5576,5567,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,SPTAN1,RPS6KB2
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4595	MUTYH
R-HSA-1483152	Hydrolysis of LPE	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	56261	GPCPD1
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	200894	ARL13B
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4121	MAN1A1
R-HSA-111458	Formation of apoptosome	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	5631	PRPS1
R-HSA-977347	Serine biosynthesis	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	29968	PSAT1
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4088	SMAD3
R-HSA-110331	Cleavage of the damaged purine	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4595	MUTYH
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	6934	TCF7L2
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	2260	FGFR1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-5602571	TRAF3 deficiency - HSE	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	7187	TRAF3
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4088	SMAD3
R-HSA-73927	Depurination	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	4595	MUTYH
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.169396607740506	-1.77551252210928	3	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.170881286868139	-1.7667861924092	104	9	0.0182926829268293	492	8202	3667,57761,2254,6464,2308,2247,2260,27327,6199	IRS1,TRIB3,FGF9,SHC1,FOXO1,FGF2,FGFR1,TNRC6A,RPS6KB2
R-HSA-73848	Pyrimidine metabolism	0.171510325575066	-1.76311180675375	24	3	0.00609756097560976	492	8202	30833,7378,4907	NT5C,UPP1,NT5E
R-HSA-375165	NCAM signaling for neurite out-growth	0.174508429037296	-1.7457822345676	266	20	0.040650406504065	492	8202	2254,200734,673,4893,8831,2335,2247,5786,8912,5908,5682,1742,9252,2260,3667,817,6464,783,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,CACNA1H,RAP1B,PSMA1,DLG4,RPS6KA5,FGFR1,IRS1,CAMK2D,SHC1,CACNB2,VCL,SPTAN1
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.174967803977378	-1.74315329925664	63	6	0.0121951219512195	492	8202	2965,2967,5984,5983,51426,27339	GTF2H1,GTF2H3,RFC4,RFC3,POLK,PRPF19
R-HSA-2559580	Oxidative Stress Induced Senescence	0.176140358355113	-1.73647411111664	119	10	0.0203252032520325	492	8202	1912,23135,23043,1019,22955,648,1021,5606,6015,27327	PHC2,KDM6B,TNIK,CDK4,SCMH1,BMI1,CDK6,MAP2K3,RING1,TNRC6A
R-HSA-191859	snRNP Assembly	0.178728828727044	-1.72188554511054	50	5	0.0101626016260163	492	8202	25929,22916,348995,23279,1207	GEMIN5,NCBP2,NUP43,NUP160,CLNS1A
R-HSA-194441	Metabolism of non-coding RNA	0.178728828727044	-1.72188554511054	50	5	0.0101626016260163	492	8202	25929,22916,348995,23279,1207	GEMIN5,NCBP2,NUP43,NUP160,CLNS1A
R-HSA-438064	Post NMDA receptor activation events	0.179177609327741	-1.71937773419582	37	4	0.00813008130081301	492	8202	1742,817,673,5567	DLG4,CAMK2D,BRAF,PRKACB
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.179177609327741	-1.71937773419582	37	4	0.00813008130081301	492	8202	2335,6464,11069,5908	FN1,SHC1,RAPGEF4,RAP1B
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.179177609327741	-1.71937773419582	37	4	0.00813008130081301	492	8202	5984,5983,51426,9636	RFC4,RFC3,POLK,ISG15
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.181266614671221	-1.70778632229697	13	2	0.0040650406504065	492	8202	3992,51	FADS1,ACOX1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.181266614671221	-1.70778632229697	13	2	0.0040650406504065	492	8202	3992,51	FADS1,ACOX1
R-HSA-75205	Dissolution of Fibrin Clot	0.181266614671221	-1.70778632229697	13	2	0.0040650406504065	492	8202	3273,6281	HRG,S100A10
R-HSA-4641265	Repression of WNT target genes	0.181266614671221	-1.70778632229697	13	2	0.0040650406504065	492	8202	7090,6934	TLE3,TCF7L2
R-HSA-190375	FGFR2c ligand binding and activation	0.181266614671221	-1.70778632229697	13	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-6782135	Dual incision in TC-NER	0.184032496065039	-1.69264292791757	64	6	0.0121951219512195	492	8202	2965,2967,5984,5983,51426,27339	GTF2H1,GTF2H3,RFC4,RFC3,POLK,PRPF19
R-HSA-3214841	PKMTs methylate histone lysines	0.184032496065039	-1.69264292791757	64	6	0.0121951219512195	492	8202	58508,10919,4297,55904,63976,79813	KMT2C,EHMT2,KMT2A,KMT2E,PRDM16,EHMT1
R-HSA-418346	Platelet homeostasis	0.185971809494327	-1.68216017861405	78	7	0.0142276422764228	492	8202	54331,5138,5140,10846,2787,5152,5139	GNG2,PDE2A,PDE3B,PDE10A,GNG5,PDE9A,PDE3A
R-HSA-69620	Cell Cycle Checkpoints	0.186464136478153	-1.67951635609411	179	14	0.0284552845528455	492	8202	8924,5984,4175,9577,5983,55388,4174,10393,8379,5682,472,672,4171,7324	HERC2,RFC4,MCM6,BRE,RFC3,MCM10,MCM5,ANAPC10,MAD1L1,PSMA1,ATM,BRCA1,MCM2,UBE2E1
R-HSA-162588	Budding and maturation of HIV virion	0.186794102525925	-1.67774832474613	25	3	0.00609756097560976	492	8202	27243,79720,92421	CHMP2A,VPS37B,CHMP4C
R-HSA-1482788	Acyl chain remodelling of PC	0.186794102525925	-1.67774832474613	25	3	0.00609756097560976	492	8202	81579,10162,79888	PLA2G12A,LPCAT3,LPCAT1
R-HSA-210991	Basigin interactions	0.186794102525925	-1.67774832474613	25	3	0.00609756097560976	492	8202	6566,6520,23657	SLC16A1,SLC3A2,SLC7A11
R-HSA-1483255	PI Metabolism	0.189130267783003	-1.66531925381537	51	5	0.0101626016260163	492	8202	23760,8871,8867,8776,5305	PITPNB,SYNJ2,SYNJ1,MTMR1,PIP4K2A
R-HSA-1592230	Mitochondrial biogenesis	0.189130267783003	-1.66531925381537	51	5	0.0101626016260163	492	8202	80205,6907,4209,133522,4208	CHD9,TBL1X,MEF2D,PPARGC1B,MEF2C
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.189130267783003	-1.66531925381537	51	5	0.0101626016260163	492	8202	2254,5578,2247,5576,5567	FGF9,PRKCA,FGF2,PRKAR2A,PRKACB
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.191466272577439	-1.65304360818382	38	4	0.00813008130081301	492	8202	7431,329,4137,6709	VIM,BIRC2,MAPT,SPTAN1
R-HSA-1442490	Collagen degradation	0.191466272577439	-1.65304360818382	38	4	0.00813008130081301	492	8202	8754,1308,4316,4323	ADAM9,COL17A1,MMP7,MMP14
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.191466272577439	-1.65304360818382	38	4	0.00813008130081301	492	8202	348995,3836,23279,9636	NUP43,KPNA1,NUP160,ISG15
R-HSA-163685	Integration of energy metabolism	0.191747626671714	-1.65157521601234	107	9	0.0182926829268293	492	8202	54331,783,11069,5578,23236,2787,5576,5567,2770	GNG2,CACNB2,RAPGEF4,PRKCA,PLCB1,GNG5,PRKAR2A,PRKACB,GNAI1
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.191747626671714	-1.65157521601234	107	9	0.0182926829268293	492	8202	57459,2967,10919,1107,25885,2965,84172,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E
R-HSA-5663205	Infectious disease	0.194759369911444	-1.63599048287803	347	25	0.0508130081300813	492	8202	27243,2967,6872,8731,6924,5682,348995,162,6829,6857,23279,9636,5606,3304,51616,6827,3836,6158,83860,79720,8907,2965,22916,7518,92421	CHMP2A,GTF2H3,TAF1,RNMT,TCEB3,PSMA1,NUP43,AP1B1,SUPT5H,SYT1,NUP160,ISG15,MAP2K3,HSPA1B,TAF9B,SUPT4H1,KPNA1,RPL28,TAF3,VPS37B,AP1M1,GTF2H1,NCBP2,XRCC4,CHMP4C
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.197586369119387	-1.62157947823709	241	18	0.0365853658536585	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5578,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-1268020	Mitochondrial protein import	0.199742588100723	-1.61072580090293	52	5	0.0101626016260163	492	8202	8604,2395,10469,23203,617	SLC25A12,FXN,TIMM44,PMPCA,BCS1L
R-HSA-75153	Apoptotic execution  phase	0.199742588100723	-1.61072580090293	52	5	0.0101626016260163	492	8202	7431,3836,329,4137,6709	VIM,KPNA1,BIRC2,MAPT,SPTAN1
R-HSA-162594	Early Phase of HIV Life Cycle	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	3836,7518	KPNA1,XRCC4
R-HSA-2024101	CS/DS degradation	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	3373,1462	HYAL1,VCAN
R-HSA-190322	FGFR4 ligand binding and activation	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-69091	Polymerase switching	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-69109	Leading Strand Synthesis	0.203544158600453	-1.59187230206	14	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-73864	RNA Polymerase I Transcription	0.206241513083696	-1.57870740329909	109	9	0.0182926829268293	492	8202	57459,2967,10919,1107,25885,2965,84172,30834,64425	GATAD2B,GTF2H3,EHMT2,CHD3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-180336	SHC1 events in EGFR signaling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-5673001	RAF/MAP kinase cascade	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-179812	GRB2 events in EGFR signaling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-112412	SOS-mediated signalling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.207948110162752	-1.57046670077511	228	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.211492413302607	-1.55356615204884	81	7	0.0142276422764228	492	8202	9140,7187,4793,3093,10010,9636,843	ATG12,TRAF3,NFKBIB,UBE2K,TANK,ISG15,CASP10
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.213030773739738	-1.54631864605725	229	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.213030773739738	-1.54631864605725	229	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.213030773739738	-1.54631864605725	229	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.213030773739738	-1.54631864605725	229	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-73894	DNA Repair	0.21609631182008	-1.53203108262059	306	22	0.0447154471544715	492	8202	8924,2967,5984,51008,5983,328,51426,10038,7156,6612,672,4292,9636,10973,9577,56852,5890,472,2965,7518,4595,27339	HERC2,GTF2H3,RFC4,ASCC1,RFC3,APEX1,POLK,PARP2,TOP3A,SUMO3,BRCA1,MLH1,ISG15,ASCC3,BRE,RAD18,RAD51B,ATM,GTF2H1,XRCC4,MUTYH,PRPF19
R-HSA-69242	S Phase	0.216563783877397	-1.52987016117729	125	10	0.0203252032520325	492	8202	5984,4175,114799,5983,328,10274,4174,1019,5682,4171	RFC4,MCM6,ESCO1,RFC3,APEX1,STAG1,MCM5,CDK4,PSMA1,MCM2
R-HSA-168253	Host Interactions with Influenza Factors	0.2167881490433	-1.52883467399514	40	4	0.00813008130081301	492	8202	348995,3836,23279,9636	NUP43,KPNA1,NUP160,ISG15
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.217317110006869	-1.52639765571749	96	8	0.016260162601626	492	8202	6541,6520,23657,81539,54407,9497,6553,8501	SLC7A1,SLC3A2,SLC7A11,SLC38A1,SLC38A2,SLC4A7,SLC9A5,SLC43A1
R-HSA-76002	Platelet activation, signaling and aggregation	0.218169682597483	-1.5224821584196	230	17	0.0345528455284553	492	8202	7273,2335,11069,5908,5578,57406,7114,2770,5583,54331,221955,6464,1191,3273,7414,11343,2787	TTN,FN1,RAPGEF4,RAP1B,PRKCA,ABHD6,TMSB4X,GNAI1,PRKCH,GNG2,DAGLB,SHC1,CLU,HRG,VCL,MGLL,GNG5
R-HSA-5655253	Signaling by FGFR2 in disease	0.218322333837187	-1.52178271265574	27	3	0.00609756097560976	492	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-437239	Recycling pathway of L1	0.218322333837187	-1.52178271265574	27	3	0.00609756097560976	492	8202	5962,26052,9252	RDX,DNM3,RPS6KA5
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	5829	PXN
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	7048	TGFBR2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	81539	SLC38A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	5366	PMAIP1
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	7048	TGFBR2
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	8829	NRP1
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	2308	FOXO1
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	328	APEX1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	6566	SLC16A1
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	27010	TPK1
R-HSA-165158	Activation of AKT2	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	57761	TRIB3
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.219238889604354	-1.51759332356639	4	1	0.00203252032520325	492	8202	81539	SLC38A1
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.22609963814756	-1.48677950010834	15	2	0.0040650406504065	492	8202	2335,5908	FN1,RAP1B
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.22609963814756	-1.48677950010834	15	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.22609963814756	-1.48677950010834	15	2	0.0040650406504065	492	8202	2335,5908	FN1,RAP1B
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.22609963814756	-1.48677950010834	15	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-170984	ARMS-mediated activation	0.228611741576043	-1.47573016596564	232	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-187706	Signalling to p38 via RIT and RIN	0.228611741576043	-1.47573016596564	232	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.229187154464835	-1.47321634080448	83	7	0.0142276422764228	492	8202	2965,6612,2967,5984,5983,51426,10038	GTF2H1,SUMO3,GTF2H3,RFC4,RFC3,POLK,PARP2
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.229775672083697	-1.47065178477783	41	4	0.00813008130081301	492	8202	1742,817,673,5567	DLG4,CAMK2D,BRAF,PRKACB
R-HSA-2172127	DAP12 interactions	0.229814842842425	-1.4704813253904	340	24	0.0487804878048781	492	8202	2254,200734,673,4893,2335,8831,2308,2247,5786,5908,5682,1742,5578,2260,3667,817,57761,6464,7414,5576,5567,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,SPTAN1,RPS6KB2
R-HSA-418555	G alpha (s) signalling events	0.23081301895704	-1.46614733797961	127	10	0.0203252032520325	492	8202	3363,54331,5141,10846,5142,5138,5140,2787,5139,2770	HTR7,GNG2,PDE4A,PDE10A,PDE4B,PDE2A,PDE3B,GNG5,PDE3A,GNAI1
R-HSA-6784531	tRNA processing in the nucleus	0.232708890387901	-1.457967004041	55	5	0.0101626016260163	492	8202	10556,10940,348995,80746,23279	RPP30,POP1,NUP43,TSEN2,NUP160
R-HSA-1250342	PI3K events in ERBB4 signaling	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-5654720	PI-3K cascade:FGFR4	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-5654689	PI-3K cascade:FGFR1	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-5654695	PI-3K cascade:FGFR2	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-5654710	PI-3K cascade:FGFR3	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-1257604	PIP3 activates AKT signaling	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-1963642	PI3K events in ERBB2 signaling	0.23371379841789	-1.45365799588596	98	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-170968	Frs2-mediated activation	0.233912561334063	-1.45280790296884	233	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.234476208890691	-1.45040115086659	28	3	0.00609756097560976	492	8202	5984,5983,56852	RFC4,RFC3,RAD18
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.234476208890691	-1.45040115086659	28	3	0.00609756097560976	492	8202	27243,79720,92421	CHMP2A,VPS37B,CHMP4C
R-HSA-111933	Calmodulin induced events	0.234476208890691	-1.45040115086659	28	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-111997	CaM pathway	0.234476208890691	-1.45040115086659	28	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-202040	G-protein activation	0.234476208890691	-1.45040115086659	28	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.24190809019713	-1.41919741753876	70	6	0.0121951219512195	492	8202	348995,3836,23279,9636,7324,2317	NUP43,KPNA1,NUP160,ISG15,UBE2E1,FLNB
R-HSA-1169408	ISG15 antiviral mechanism	0.24190809019713	-1.41919741753876	70	6	0.0121951219512195	492	8202	348995,3836,23279,9636,7324,2317	NUP43,KPNA1,NUP160,ISG15,UBE2E1,FLNB
R-HSA-169893	Prolonged ERK activation events	0.244667717604468	-1.40785424365885	235	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.248819829485746	-1.39102622078762	16	2	0.0040650406504065	492	8202	8091,57634	HMGA2,EP400
R-HSA-110312	Translesion synthesis by REV1	0.248819829485746	-1.39102622078762	16	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.248819829485746	-1.39102622078762	16	2	0.0040650406504065	492	8202	5283,54872	PIGH,PIGG
R-HSA-163615	PKA activation	0.248819829485746	-1.39102622078762	16	2	0.0040650406504065	492	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-446353	Cell-extracellular matrix interactions	0.248819829485746	-1.39102622078762	16	2	0.0040650406504065	492	8202	2318,5829	FLNC,PXN
R-HSA-2586552	Signaling by Leptin	0.250119538204017	-1.38581632258245	236	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	80205,6907,28996	CHD9,TBL1X,HIPK2
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-180786	Extension of Telomeres	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	348995,3836,23279	NUP43,KPNA1,NUP160
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	847,9588,475	CAT,PRDX6,ATOX1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.250831965575945	-1.38297202389546	29	3	0.00609756097560976	492	8202	1742,817,673	DLG4,CAMK2D,BRAF
R-HSA-186797	Signaling by PDGF	0.252123344961368	-1.3778368470868	345	24	0.0487804878048781	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5576,5567,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKAR2A,PRKACB,TNRC6A,RPS6KB2,SPTAN1
R-HSA-5663202	Diseases of signal transduction	0.256075811228362	-1.36228174073187	268	19	0.0386178861788618	492	8202	2254,4893,2308,2247,1523,5682,54894,7048,2260,6934,22943,3667,4088,182,6464,6907,5947,6199,55534	FGF9,NRAS,FOXO1,FGF2,CUX1,PSMA1,RNF43,TGFBR2,FGFR1,TCF7L2,DKK1,IRS1,SMAD3,JAG1,SHC1,TBL1X,RBP1,RPS6KB2,MAML3
R-HSA-917937	Iron uptake and transport	0.256290472919462	-1.36144381790088	43	4	0.00813008130081301	492	8202	535,30061,3163,28982	ATP6V0A1,SLC40A1,HMOX2,FLVCR1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.256290472919462	-1.36144381790088	43	4	0.00813008130081301	492	8202	54331,5576,2787,5567	GNG2,PRKAR2A,GNG5,PRKACB
R-HSA-381119	Unfolded Protein Response (UPR)	0.256616009231421	-1.3601744389127	86	7	0.0142276422764228	492	8202	7709,440,468,6464,5073,9709,1649	ZBTB17,ASNS,ATF4,SHC1,PARN,HERPUD1,DDIT3
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.256616009231421	-1.3601744389127	86	7	0.0142276422764228	492	8202	7273,1191,2335,3273,5578,7414,7114	TTN,CLU,FN1,HRG,PRKCA,VCL,TMSB4X
R-HSA-198203	PI3K/AKT activation	0.259075536125819	-1.35063561452938	101	8	0.016260162601626	492	8202	3667,57761,2254,2308,2247,2260,6199,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2,TNRC6A
R-HSA-912526	Interleukin receptor SHC signaling	0.261165162386208	-1.34260226571936	238	17	0.0345528455284553	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.262306824848428	-1.33824037320103	72	6	0.0121951219512195	492	8202	4088,6498,56937,7048,51377,4092	SMAD3,SKIL,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-75157	FasL/ CD95L signaling	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	843	CASP10
R-HSA-3000471	Scavenging by Class B Receptors	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	949	SCARB1
R-HSA-74713	IRS activation	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	3667	IRS1
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	5567	PRKACB
R-HSA-114516	Disinhibition of SNARE formation	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-71032	Propionyl-CoA catabolism	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	317	APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	4121	MAN1A1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	317	APAF1
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	115677	NOSTRIN
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	440193	CCDC88C
R-HSA-1169092	Activation of RAS in B cells	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	4893	NRAS
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	9942	XYLB
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.266095984788431	-1.32389819022007	5	1	0.00203252032520325	492	8202	6612	SUMO3
R-HSA-167044	Signalling to RAS	0.266756285366052	-1.32141982631854	239	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-399719	Trafficking of AMPA receptors	0.267348188350201	-1.31920339393278	30	3	0.00609756097560976	492	8202	1742,817,5578	DLG4,CAMK2D,PRKCA
R-HSA-111996	Ca-dependent events	0.267348188350201	-1.31920339393278	30	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.267348188350201	-1.31920339393278	30	3	0.00609756097560976	492	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.267348188350201	-1.31920339393278	30	3	0.00609756097560976	492	8202	1742,817,5578	DLG4,CAMK2D,PRKCA
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.267348188350201	-1.31920339393278	30	3	0.00609756097560976	492	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.26977311619878	-1.31017398361733	44	4	0.00813008130081301	492	8202	2965,6612,2967,10038	GTF2H1,SUMO3,GTF2H3,PARP2
R-HSA-2033519	Activated point mutants of FGFR2	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-1839126	FGFR2 mutant receptor activation	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-5656121	Translesion synthesis by POLI	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	1742,817	DLG4,CAMK2D
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	1742,817	DLG4,CAMK2D
R-HSA-176412	Phosphorylation of the APC/C	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-1482925	Acyl chain remodelling of PG	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	81579,79888	PLA2G12A,LPCAT1
R-HSA-164378	PKA activation in glucagon signalling	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	5576,5567	PRKAR2A,PRKACB
R-HSA-1482801	Acyl chain remodelling of PS	0.2716040422188	-1.30341000042308	17	2	0.0040650406504065	492	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-112315	Transmission across Chemical Synapses	0.278160813067118	-1.27955586826725	210	15	0.0304878048780488	492	8202	2744,54331,817,673,81539,10550,783,54407,1742,5578,6857,23236,2787,5567,2770	GLS,GNG2,CAMK2D,BRAF,SLC38A1,ARL6IP5,CACNB2,SLC38A2,DLG4,PRKCA,SYT1,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-194138	Signaling by VEGF	0.282342216817625	-1.26463540896796	320	22	0.0447154471544715	492	8202	2254,200734,5829,673,4893,8831,2335,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,8829,7414,5567,6709	FGF9,SPRED2,PXN,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,NRP1,VCL,PRKACB,SPTAN1
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-167287	HIV elongation arrest and recovery	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-167290	Pausing and recovery of HIV elongation	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	6827,6829,6924	SUPT4H1,SUPT5H,TCEB3
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	348995,23279,3304	NUP43,NUP160,HSPA1B
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	4316,4325,4323	MMP7,MMP16,MMP14
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.28398524252221	-1.25883300512102	31	3	0.00609756097560976	492	8202	348995,3836,23279	NUP43,KPNA1,NUP160
R-HSA-1474228	Degradation of the extracellular matrix	0.284940453210224	-1.25547505664815	89	7	0.0142276422764228	492	8202	8754,1308,4316,960,3911,4325,4323	ADAM9,COL17A1,MMP7,CD44,LAMA5,MMP16,MMP14
R-HSA-427413	NoRC negatively regulates rRNA expression	0.28522736492457	-1.254468645099	104	8	0.016260162601626	492	8202	2967,25885,2965,84172,30834,64425,29115,8819	GTF2H3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E,SAP30BP,SAP30
R-HSA-5693538	Homology Directed Repair	0.29097974466686	-1.23450162018906	135	10	0.0203252032520325	492	8202	8924,5984,9577,5983,51426,10038,5890,7156,472,672	HERC2,RFC4,BRE,RFC3,POLK,PARP2,RAD51B,TOP3A,ATM,BRCA1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.294363028072981	-1.22294148400498	18	2	0.0040650406504065	492	8202	7187,10010	TRAF3,TANK
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.294363028072981	-1.22294148400498	18	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.294363028072981	-1.22294148400498	18	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-392518	Signal amplification	0.300705355939968	-1.20162437757339	32	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.300705355939968	-1.20162437757339	32	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.301134997124254	-1.20019661934786	121	9	0.0182926829268293	492	8202	26052,8651,10010,7187,4793,9252,329,5606,4208	DNM3,SOCS1,TANK,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-451927	Interleukin-2 signaling	0.301171211075865	-1.20007636838195	245	17	0.0345528455284553	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-69306	DNA Replication	0.303026750734293	-1.19393419111798	106	8	0.016260162601626	492	8202	5984,4175,5983,55388,328,4174,5682,4171	RFC4,MCM6,RFC3,MCM10,APEX1,MCM5,PSMA1,MCM2
R-HSA-112399	IRS-mediated signalling	0.304414305181786	-1.1893656594149	277	19	0.0386178861788618	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-422475	Axon guidance	0.306263473463638	-1.18330952310764	516	34	0.0691056910569106	492	8202	1948,200734,26052,673,2335,71,5786,7204,8912,55740,9252,57556,6464,783,5962,7414,6709,2254,4893,51466,3786,8831,2247,287,5908,5682,1742,23365,2260,3667,817,3673,23114,8829	EFNB2,SPRED2,DNM3,BRAF,FN1,ACTG1,PTPRA,TRIO,CACNA1H,ENAH,RPS6KA5,SEMA6A,SHC1,CACNB2,RDX,VCL,SPTAN1,FGF9,NRAS,EVL,KCNQ3,SYNGAP1,FGF2,ANK2,RAP1B,PSMA1,DLG4,ARHGEF12,FGFR1,IRS1,CAMK2D,ITGA2,NFASC,NRP1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.30667024864266	-1.18198221731888	137	10	0.0203252032520325	492	8202	10019,3048,2627,3798,5890,11311,56992,5576,5567,23028	SH2B3,HBG2,GATA6,KIF5A,RAD51B,VPS45,KIF15,PRKAR2A,PRKACB,KDM1A
R-HSA-187687	Signalling to ERKs	0.307038181530526	-1.18078316932195	246	17	0.0345528455284553	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	11343	MGLL
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	55253	TYW1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	51	ACOX1
R-HSA-1482798	Acyl chain remodeling of CL	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	253558	LCLAT1
R-HSA-1566977	Fibronectin matrix formation	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	2335	FN1
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	472	ATM
R-HSA-947581	Molybdenum cofactor biosynthesis	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	10243	GPHN
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	6612	SUMO3
R-HSA-3065679	SUMO is proteolytically processed	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	6612	SUMO3
R-HSA-211916	Vitamins	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	1591	CYP24A1
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	673	BRAF
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	22943	DKK1
R-HSA-189483	Heme degradation	0.310146341681993	-1.17071102295099	6	1	0.00203252032520325	492	8202	3163	HMOX2
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.312019003184236	-1.16469118538567	107	8	0.016260162601626	492	8202	2967,25885,2965,84172,30834,64425,29115,8819	GTF2H3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E,SAP30BP,SAP30
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.314999284206377	-1.15518491251979	77	6	0.0121951219512195	492	8202	2965,2967,5984,5983,51426,27339	GTF2H1,GTF2H3,RFC4,RFC3,POLK,PRPF19
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-110320	Translesion Synthesis by POLH	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	5984,5983	RFC4,RFC3
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	1742,817	DLG4,CAMK2D
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-1643713	Signaling by EGFR in Cancer	0.317017975094018	-1.14879680294584	19	2	0.0040650406504065	492	8202	4893,6464	NRAS,SHC1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.317472675878301	-1.14736352457861	33	3	0.00609756097560976	492	8202	5087,2247,2649	PBX1,FGF2,NR6A1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.317472675878301	-1.14736352457861	33	3	0.00609756097560976	492	8202	348995,10783,23279	NUP43,NEK6,NUP160
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.317472675878301	-1.14736352457861	33	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-2871796	FCERI mediated MAPK activation	0.318871071510273	-1.14296842243839	248	17	0.0345528455284553	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-74751	Insulin receptor signalling cascade	0.321133085042374	-1.13589964662536	280	19	0.0386178861788618	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.322627532305847	-1.13125677190528	312	21	0.0426829268292683	492	8202	2254,200734,5829,673,4893,8831,2335,2247,5786,5908,5682,1742,5578,2260,3667,57761,817,6464,7414,5567,6709	FGF9,SPRED2,PXN,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKACB,SPTAN1
R-HSA-1236394	Signaling by ERBB4	0.322627532305847	-1.13125677190528	312	21	0.0426829268292683	492	8202	2254,200734,673,4893,8831,2335,2308,2247,5786,5908,5682,1742,2260,3667,817,57761,6464,7414,27327,6199,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,TNRC6A,RPS6KB2,SPTAN1
R-HSA-2428924	IGF1R signaling cascade	0.326762542990081	-1.11852154009879	281	19	0.0386178861788618	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.326762542990081	-1.11852154009879	281	19	0.0386178861788618	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.326762542990081	-1.11852154009879	281	19	0.0386178861788618	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-5696398	Nucleotide Excision Repair	0.33016039513697	-1.10817669673404	109	8	0.016260162601626	492	8202	2967,5984,5983,51426,10038,6612,2965,27339	GTF2H3,RFC4,RFC3,POLK,PARP2,SUMO3,GTF2H1,PRPF19
R-HSA-168898	Toll-Like Receptors Cascades	0.330571126577416	-1.10693343383571	140	10	0.0203252032520325	492	8202	26052,8651,10010,7187,4793,9252,329,8411,5606,4208	DNM3,SOCS1,TANK,TRAF3,NFKBIB,RPS6KA5,BIRC2,EEA1,MAP2K3,MEF2C
R-HSA-390522	Striated Muscle Contraction	0.334253304320386	-1.09585617727367	34	3	0.00609756097560976	492	8202	7134,7431,7273	TNNC1,VIM,TTN
R-HSA-4791275	Signaling by WNT in cancer	0.334253304320386	-1.09585617727367	34	3	0.00609756097560976	492	8202	54894,6934,22943	RNF43,TCF7L2,DKK1
R-HSA-1489509	DAG and IP3 signaling	0.334253304320386	-1.09585617727367	34	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.334253304320386	-1.09585617727367	34	3	0.00609756097560976	492	8202	2254,673,2247	FGF9,BRAF,FGF2
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.334253304320386	-1.09585617727367	34	3	0.00609756097560976	492	8202	348995,3836,23279	NUP43,KPNA1,NUP160
R-HSA-109704	PI3K Cascade	0.336553033062633	-1.08899954034605	79	6	0.0121951219512195	492	8202	3667,57761,2254,2247,5140,2260	IRS1,TRIB3,FGF9,FGF2,PDE3B,FGFR1
R-HSA-190241	FGFR2 ligand binding and activation	0.339499580876282	-1.08028256651645	20	2	0.0040650406504065	492	8202	2254,2247	FGF9,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.339499580876282	-1.08028256651645	20	2	0.0040650406504065	492	8202	11343,5567	MGLL,PRKACB
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.339499580876282	-1.08028256651645	20	2	0.0040650406504065	492	8202	1803,6934	DPP4,TCF7L2
R-HSA-397014	Muscle contraction	0.350636459179399	-1.04800532108764	65	5	0.0101626016260163	492	8202	7134,7431,7273,5829,7414	TNNC1,VIM,TTN,PXN,VCL
R-HSA-432720	Lysosome Vesicle Biogenesis	0.351015314439792	-1.04692542558547	35	3	0.00609756097560976	492	8202	27243,162,8907	CHMP2A,AP1B1,AP1M1
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.351015314439792	-1.04692542558547	35	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	5567	PRKACB
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-447043	Neurofascin interactions	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	23114	NFASC
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	7112	TMPO
R-HSA-199920	CREB phosphorylation	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	9252	RPS6KA5
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	148867	SLC30A7
R-HSA-447038	NrCAM interactions	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	1742	DLG4
R-HSA-111471	Apoptotic factor-mediated response	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	317	APAF1
R-HSA-75158	TRAIL  signaling	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	843	CASP10
R-HSA-196791	Vitamin D (calciferol) metabolism	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-190371	FGFR3b ligand binding and activation	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	2254	FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	25945	PVRL3
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	5226	PGD
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	10783	NEK6
R-HSA-164843	2-LTR circle formation	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	7518	XRCC4
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	27327	TNRC6A
R-HSA-2142789	Ubiquinol biosynthesis	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	57107	PDSS2
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.351557761876583	-1.04538125156895	7	1	0.00203252032520325	492	8202	6934	TCF7L2
R-HSA-112310	Neurotransmitter Release Cycle	0.352484015652725	-1.04275000342399	50	4	0.00813008130081301	492	8202	2744,6857,10550,54407	GLS,SYT1,ARL6IP5,SLC38A2
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.355049938114529	-1.03549682865477	254	17	0.0345528455284553	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-166054	Activated TLR4 signalling	0.35768043146391	-1.02811534077244	112	8	0.016260162601626	492	8202	8651,10010,7187,4793,9252,329,5606,4208	SOCS1,TANK,TRAF3,NFKBIB,RPS6KA5,BIRC2,MAP2K3,MEF2C
R-HSA-114608	Platelet degranulation	0.358266561590187	-1.02647798420021	81	6	0.0121951219512195	492	8202	7273,1191,2335,3273,7414,7114	TTN,CLU,FN1,HRG,VCL,TMSB4X
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	162,8907	AP1B1,AP1M1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	50515,1462	CHST11,VCAN
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	57761,9020	TRIB3,MAP3K14
R-HSA-198753	ERK/MAPK targets	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-445144	Signal transduction by L1	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	8829,2260	NRP1,FGFR1
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-5620916	VxPx cargo-targeting to cilium	0.361747199101401	-1.01680965613659	21	2	0.0040650406504065	492	8202	50807,60412	ASAP1,EXOC4
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.363379114083848	-1.01230859829902	97	7	0.0142276422764228	492	8202	7187,4793,9252,329,10010,5606,4208	TRAF3,NFKBIB,RPS6KA5,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.363379114083848	-1.01230859829902	97	7	0.0142276422764228	492	8202	7187,4793,9252,329,10010,5606,4208	TRAF3,NFKBIB,RPS6KA5,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.363379114083848	-1.01230859829902	97	7	0.0142276422764228	492	8202	7187,4793,9252,329,10010,5606,4208	TRAF3,NFKBIB,RPS6KA5,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-5693607	Processing of DNA double-strand break ends	0.363379114083848	-1.01230859829902	97	7	0.0142276422764228	492	8202	8924,472,5984,672,9577,5983,7156	HERC2,ATM,RFC4,BRCA1,BRE,RFC3,TOP3A
R-HSA-445717	Aquaporin-mediated transport	0.36638646227542	-1.00406659480302	51	4	0.00813008130081301	492	8202	54331,5576,2787,5567	GNG2,PRKAR2A,GNG5,PRKACB
R-HSA-397795	G-protein beta:gamma signalling	0.36638646227542	-1.00406659480302	51	4	0.00813008130081301	492	8202	54331,6464,23236,2787	GNG2,SHC1,PLCB1,GNG5
R-HSA-74752	Signaling by Insulin receptor	0.36645320384833	-1.00388444971405	304	20	0.040650406504065	492	8202	2254,200734,673,4893,8831,2335,2247,5786,5908,5682,1742,535,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,ATP6V0A1,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-167021	PLC-gamma1 signalling	0.367728750909266	-1.00040970251801	36	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.367728750909266	-1.00040970251801	36	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.367728750909266	-1.00040970251801	36	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.369391170988936	-0.995899112452993	129	9	0.0182926829268293	492	8202	8924,5984,9577,5983,51426,5890,7156,472,672	HERC2,RFC4,BRE,RFC3,POLK,RAD51B,TOP3A,ATM,BRCA1
R-HSA-69239	Synthesis of DNA	0.373353369137324	-0.985229937469028	98	7	0.0142276422764228	492	8202	5682,5984,4175,5983,328,4171,4174	PSMA1,RFC4,MCM6,RFC3,APEX1,MCM2,MCM5
R-HSA-5693532	DNA Double-Strand Break Repair	0.380089930705475	-0.967347394509957	162	11	0.0223577235772358	492	8202	8924,5984,9577,5983,51426,10038,5890,7156,472,672,7518	HERC2,RFC4,BRE,RFC3,POLK,PARP2,RAD51B,TOP3A,ATM,BRCA1,XRCC4
R-HSA-5610787	Hedgehog 'off' state	0.383342259784865	-0.958827060168775	99	7	0.0142276422764228	492	8202	5682,55081,79659,57539,5576,5567,54903	PSMA1,IFT57,DYNC2H1,WDR35,PRKAR2A,PRKACB,MKS1
R-HSA-373753	Nephrin interactions	0.383708053916649	-0.957873291809699	22	2	0.0040650406504065	492	8202	84063,6709	KIRREL2,SPTAN1
R-HSA-3371571	HSF1-dependent transactivation	0.383708053916649	-0.957873291809699	22	2	0.0040650406504065	492	8202	817,3304	CAMK2D,HSPA1B
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.383708053916649	-0.957873291809699	22	2	0.0040650406504065	492	8202	2247,2649	FGF2,NR6A1
R-HSA-156590	Glutathione conjugation	0.384365616348794	-0.956161053470455	37	3	0.00609756097560976	492	8202	2678,2941,4257	GGT1,GSTA4,MGST1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.384365616348794	-0.956161053470455	37	3	0.00609756097560976	492	8202	5578,5576,5567	PRKCA,PRKAR2A,PRKACB
R-HSA-1500620	Meiosis	0.385437053616285	-0.953377384353269	115	8	0.016260162601626	492	8202	54386,10274,1019,7156,472,4292,4438,672	TERF2IP,STAG1,CDK4,TOP3A,ATM,MLH1,MSH4,BRCA1
R-HSA-1500931	Cell-Cell communication	0.386747322345054	-0.949983713030487	131	9	0.0182926829268293	492	8202	667,2318,1308,5829,8935,84063,25945,3691,6709	DST,FLNC,COL17A1,PXN,SKAP2,KIRREL2,PVRL3,ITGB4,SPTAN1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.387032463954075	-0.949246703284365	68	5	0.0101626016260163	492	8202	8924,472,672,9577,7518	HERC2,ATM,BRCA1,BRE,XRCC4
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.387032463954075	-0.949246703284365	68	5	0.0101626016260163	492	8202	472,348995,23279,573,3304	ATM,NUP43,NUP160,BAG1,HSPA1B
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	54894	RNF43
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	5366	PMAIP1
R-HSA-1483115	Hydrolysis of LPC	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	56261	GPCPD1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	23236	PLCB1
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	23236	PLCB1
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	57761	TRIB3
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	89978	DPH6
R-HSA-72731	Recycling of eIF2:GDP	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	8891	EIF2B3
R-HSA-2046105	Linoleic acid (LA) metabolism	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	3992	FADS1
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	5829	PXN
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.3904880341345	-0.94035795259314	8	1	0.00203252032520325	492	8202	57142	RTN4
R-HSA-912446	Meiotic recombination	0.390979007600096	-0.93910140944039	84	6	0.0121951219512195	492	8202	472,672,4438,4292,1019,7156	ATM,BRCA1,MSH4,MLH1,CDK4,TOP3A
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.400899845813968	-0.91404364393348	38	3	0.00609756097560976	492	8202	5533,317,5366	PPP3CC,APAF1,PMAIP1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.401265230615278	-0.913132647338598	424	27	0.0548780487804878	492	8202	2254,200734,673,4893,8831,2335,2247,5786,4923,7204,5908,5682,1742,5578,23236,57406,2260,54331,3667,5583,817,6464,221955,7414,11343,2787,6709	FGF9,SPRED2,BRAF,NRAS,SYNGAP1,FN1,FGF2,PTPRA,NTSR1,TRIO,RAP1B,PSMA1,DLG4,PRKCA,PLCB1,ABHD6,FGFR1,GNG2,IRS1,PRKCH,CAMK2D,SHC1,DAGLB,VCL,MGLL,GNG5,SPTAN1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.401886470173387	-0.911585642753048	85	6	0.0121951219512195	492	8202	3667,2254,2308,2247,2260,6199	IRS1,FGF9,FOXO1,FGF2,FGFR1,RPS6KB2
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	1803,6934	DPP4,TCF7L2
R-HSA-1482839	Acyl chain remodelling of PE	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	4088,6498	SMAD3,SKIL
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	7324,10393	UBE2E1,ANAPC10
R-HSA-428930	Thromboxane signalling through TP receptor	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.405336517181226	-0.903037650267092	23	2	0.0040650406504065	492	8202	2678,1800	GGT1,DPEP1
R-HSA-446728	Cell junction organization	0.412781754745209	-0.884836264567719	86	6	0.0121951219512195	492	8202	667,2318,1308,5829,3691,25945	DST,FLNC,COL17A1,PXN,ITGB4,PVRL3
R-HSA-2980736	Peptide hormone metabolism	0.412781754745209	-0.884836264567719	86	6	0.0121951219512195	492	8202	3800,1803,3798,6934,60412,148867	KIF5C,DPP4,KIF5A,TCF7L2,EXOC4,SLC30A7
R-HSA-3371556	Cellular response to heat stress	0.412781754745209	-0.884836264567719	86	6	0.0121951219512195	492	8202	472,817,348995,23279,573,3304	ATM,CAMK2D,NUP43,NUP160,BAG1,HSPA1B
R-HSA-425407	SLC-mediated transmembrane transport	0.416856438916167	-0.875013387642517	264	17	0.0345528455284553	492	8202	30061,6520,81539,348995,23279,6553,148867,6541,23516,23657,7922,54407,3099,9497,6566,861,8501	SLC40A1,SLC3A2,SLC38A1,NUP43,NUP160,SLC9A5,SLC30A7,SLC7A1,SLC39A14,SLC7A11,SLC39A7,SLC38A2,HK2,SLC4A7,SLC16A1,RUNX1,SLC43A1
R-HSA-977444	GABA B receptor activation	0.417307271451795	-0.873932466538133	39	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-991365	Activation of GABAB receptors	0.417307271451795	-0.873932466538133	39	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.423656886068308	-0.858831382325283	87	6	0.0121951219512195	492	8202	5682,677,5578,5073,26986,3304	PSMA1,ZFP36L1,PRKCA,PARN,PABPC1,HSPA1B
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.426593443687079	-0.851923841822766	24	2	0.0040650406504065	492	8202	2308,6199	FOXO1,RPS6KB2
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.426593443687079	-0.851923841822766	24	2	0.0040650406504065	492	8202	7187,4793	TRAF3,NFKBIB
R-HSA-70268	Pyruvate metabolism	0.426593443687079	-0.851923841822766	24	2	0.0040650406504065	492	8202	6566,51660	SLC16A1,MPC1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.426593443687079	-0.851923841822766	24	2	0.0040650406504065	492	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-5260271	Diseases of Immune System	0.426593443687079	-0.851923841822766	24	2	0.0040650406504065	492	8202	7187,4793	TRAF3,NFKBIB
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.42694518398943	-0.851099648726268	168	11	0.0223577235772358	492	8202	3667,57761,2254,4893,2308,2247,5682,4793,2260,27327,6199	IRS1,TRIB3,FGF9,NRAS,FOXO1,FGF2,PSMA1,NFKBIB,FGFR1,TNRC6A,RPS6KB2
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	2395	FXN
R-HSA-425986	Sodium/Proton exchangers	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	6553	SLC9A5
R-HSA-425381	Bicarbonate transporters	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	9497	SLC4A7
R-HSA-73614	Pyrimidine salvage reactions	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	7378	UPP1
R-HSA-112411	MAPK1 (ERK2) activation	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	3570	IL6R
R-HSA-193697	p75NTR regulates axonogenesis	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	57142	RTN4
R-HSA-3215018	Processing and activation of SUMO	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	6612	SUMO3
R-HSA-1462054	Alpha-defensins	0.427085530741756	-0.850770979625337	9	1	0.00203252032520325	492	8202	5646	PRSS3
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.433565578665011	-0.835712217005524	40	3	0.00609756097560976	492	8202	5451,10302,4774	POU2F1,SNAPC5,NFIA
R-HSA-74158	RNA Polymerase III Transcription	0.433565578665011	-0.835712217005524	40	3	0.00609756097560976	492	8202	5451,10302,4774	POU2F1,SNAPC5,NFIA
R-HSA-73777	RNA Polymerase I Chain Elongation	0.434504119864627	-0.833549852469797	88	6	0.0121951219512195	492	8202	2965,2967,84172,30834,64425,25885	GTF2H1,GTF2H3,POLR1B,ZNRD1,POLR1E,POLR1A
R-HSA-69300	Removal of licensing factors from origins	0.435324139978461	-0.83166437600364	72	5	0.0101626016260163	492	8202	5682,4175,55388,4171,4174	PSMA1,MCM6,MCM10,MCM2,MCM5
R-HSA-3000178	ECM proteoglycans	0.435343445980178	-0.831620028420171	56	4	0.00813008130081301	492	8202	3910,3911,1462,3673	LAMA4,LAMA5,VCAN,ITGA2
R-HSA-5673000	RAF activation	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	673,4893	BRAF,NRAS
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-1296059	G protein gated Potassium channels	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-114452	Activation of BH3-only proteins	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	5533,5366	PPP3CC,PMAIP1
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	5283,54872	PIGH,PIGG
R-HSA-982772	Growth hormone receptor signaling	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	3667,8651	IRS1,SOCS1
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-1296041	Activation of G protein gated Potassium channels	0.447445560318516	-0.804200401587061	25	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-5620924	Intraflagellar transport	0.449654255498477	-0.799276312642205	41	3	0.00609756097560976	492	8202	79659,55081,57539	DYNC2H1,IFT57,WDR35
R-HSA-70153	Glucose transport	0.449654255498477	-0.799276312642205	41	3	0.00609756097560976	492	8202	348995,23279,3099	NUP43,NUP160,HK2
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-168799	Neurotoxicity of clostridium toxins	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	4595	MUTYH
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	10038	PARP2
R-HSA-2474795	Diseases associated with visual transduction	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	5947	RBP1
R-HSA-2470946	Cohesin Loading onto Chromatin	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	10274	STAG1
R-HSA-549127	Organic cation transport	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	861	RUNX1
R-HSA-110056	MAPK3 (ERK1) activation	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	3570	IL6R
R-HSA-2453864	Retinoid cycle disease events	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	5947	RBP1
R-HSA-190377	FGFR2b ligand binding and activation	0.461489768369154	-0.773295395666029	10	1	0.00203252032520325	492	8202	2247	FGF2
R-HSA-1280218	Adaptive Immune System	0.462615663941936	-0.770858669096717	668	41	0.0833333333333333	492	8202	8924,26052,2308,9871,3798,55740,162,10666,55824,6464,8651,51164,10393,8907,26046,79659,9020,90678,5567,6199,2254,4893,51466,2247,11069,56992,5908,5682,3093,23352,7324,2260,1525,114876,1778,3667,57761,57630,51444,4793,27327	HERC2,DNM3,FOXO1,SEC24D,KIF5A,ENAH,AP1B1,CD226,PAG1,SHC1,SOCS1,DCTN4,ANAPC10,AP1M1,LTN1,DYNC2H1,MAP3K14,LRSAM1,PRKACB,RPS6KB2,FGF9,NRAS,EVL,FGF2,RAPGEF4,KIF15,RAP1B,PSMA1,UBE2K,UBR4,UBE2E1,FGFR1,CXADR,OSBPL1A,DYNC1H1,IRS1,TRIB3,SH3RF1,RNF138,NFKBIB,TNRC6A
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.46555453631031	-0.764526032714165	42	3	0.00609756097560976	492	8202	6659,7090,6934	SOX4,TLE3,TCF7L2
R-HSA-983189	Kinesins	0.467864904779643	-0.759575689737013	26	2	0.0040650406504065	492	8202	3798,56992	KIF5A,KIF15
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.467864904779643	-0.759575689737013	26	2	0.0040650406504065	492	8202	51384,79971	WNT16,WLS
R-HSA-212165	Epigenetic regulation of gene expression	0.468703937843986	-0.757783972458759	124	8	0.016260162601626	492	8202	2967,25885,2965,84172,30834,64425,29115,8819	GTF2H3,POLR1A,GTF2H1,POLR1B,ZNRD1,POLR1E,SAP30BP,SAP30
R-HSA-416482	G alpha (12/13) signalling events	0.471000400116987	-0.7528963354608	75	5	0.0101626016260163	492	8202	54331,84033,23365,2787,7204	GNG2,OBSCN,ARHGEF12,GNG5,TRIO
R-HSA-69304	Regulation of DNA replication	0.471000400116987	-0.7528963354608	75	5	0.0101626016260163	492	8202	5682,4175,55388,4171,4174	PSMA1,MCM6,MCM10,MCM2,MCM5
R-HSA-71387	Metabolism of carbohydrates	0.479178364008139	-0.735682383433633	274	17	0.0345528455284553	492	8202	9942,50515,57214,8604,348995,23279,5226,3038,1462,3099,3373,960,5106,5631,5567,6576,9653	XYLB,CHST11,CEMIP,SLC25A12,NUP43,NUP160,PGD,HAS3,VCAN,HK2,HYAL1,CD44,PCK2,PRPS1,PRKACB,SLC25A1,HS2ST1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.481249341071776	-0.731369762582585	43	3	0.00609756097560976	492	8202	4088,6498,4092	SMAD3,SKIL,SMAD7
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.482116469529567	-0.729569556093156	142	9	0.0182926829268293	492	8202	54331,817,673,1742,5578,23236,2787,5567,2770	GNG2,CAMK2D,BRAF,DLG4,PRKCA,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-182971	EGFR downregulation	0.487828310450696	-0.717791757880102	27	2	0.0040650406504065	492	8202	58513,5796	EPS15L1,PTPRK
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.487828310450696	-0.717791757880102	27	2	0.0040650406504065	492	8202	23236,8867	PLCB1,SYNJ1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.488837400619306	-0.715725358873276	342	21	0.0426829268292683	492	8202	2254,200734,673,4893,2335,8831,2308,2247,5786,5908,5682,1742,2260,3667,817,57761,6464,7414,27327,6709,6199	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,TNRC6A,SPTAN1,RPS6KB2
R-HSA-2022923	Dermatan sulfate biosynthesis	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-5625970	RHO GTPases activate KTN1	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	3798	KIF5A
R-HSA-71288	Creatine metabolism	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	6535	SLC6A8
R-HSA-1980148	Signaling by NOTCH3	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-1059683	Interleukin-6 signaling	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	3570	IL6R
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	79720	VPS37B
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	79720	VPS37B
R-HSA-5655291	Signaling by FGFR4 in disease	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	4893	NRAS
R-HSA-1980150	Signaling by NOTCH4	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.493831935597382	-0.705560031020555	11	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-70326	Glucose metabolism	0.494388098725736	-0.704434445285079	77	5	0.0101626016260163	492	8202	8604,5106,5567,6576,3099	SLC25A12,PCK2,PRKACB,SLC25A1,HK2
R-HSA-382556	ABC-family proteins mediated transport	0.496723211179205	-0.699722327179112	44	3	0.00609756097560976	492	8202	8714,1244,10347	ABCC3,ABCC2,ABCA7
R-HSA-3214815	HDACs deacetylate histones	0.498598979132046	-0.695953155363596	94	6	0.0121951219512195	492	8202	57459,6907,1107,317772,23028,8819	GATAD2B,TBL1X,CHD3,HIST2H2AB,KDM1A,SAP30
R-HSA-3858494	Beta-catenin independent WNT signaling	0.499180049726326	-0.694788427216053	144	9	0.0182926829268293	492	8202	54331,7976,5682,5578,23236,2787,5881,6934,27327	GNG2,FZD3,PSMA1,PRKCA,PLCB1,GNG5,RAC3,TCF7L2,TNRC6A
R-HSA-913531	Interferon Signaling	0.499490095435613	-0.694167510047857	194	12	0.024390243902439	492	8202	5771,817,3836,8651,3460,348995,960,10581,23279,9636,2317,7324	PTPN2,CAMK2D,KPNA1,SOCS1,IFNGR2,NUP43,CD44,IFITM2,NUP160,ISG15,FLNB,UBE2E1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.502052482644039	-0.689050617655396	61	4	0.00813008130081301	492	8202	3667,2254,2247,2260	IRS1,FGF9,FGF2,FGFR1
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.507316933652723	-0.678619355008533	28	2	0.0040650406504065	492	8202	5451,10302	POU2F1,SNAPC5
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.507316933652723	-0.678619355008533	28	2	0.0040650406504065	492	8202	162,8907	AP1B1,AP1M1
R-HSA-193648	NRAGE signals death through JNK	0.511962242795551	-0.669504401201832	45	3	0.00609756097560976	492	8202	84033,23365,7204	OBSCN,ARHGEF12,TRIO
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.511962242795551	-0.669504401201832	45	3	0.00609756097560976	492	8202	6566,8802,51660	SLC16A1,SUCLG1,MPC1
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	843	CASP10
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	1742	DLG4
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	1742	DLG4
R-HSA-390666	Serotonin receptors	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	3363	HTR7
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	55534	MAML3
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	328	APEX1
R-HSA-211979	Eicosanoids	0.52423538911743	-0.645814479655381	12	1	0.00203252032520325	492	8202	6916	TBXAS1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.526315820179873	-0.641853827830637	29	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.526315820179873	-0.641853827830637	29	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.526315820179873	-0.641853827830637	29	2	0.0040650406504065	492	8202	27327,55534	TNRC6A,MAML3
R-HSA-445355	Smooth Muscle Contraction	0.526315820179873	-0.641853827830637	29	2	0.0040650406504065	492	8202	5829,7414	PXN,VCL
R-HSA-5339562	Uptake and actions of bacterial toxins	0.526315820179873	-0.641853827830637	29	2	0.0040650406504065	492	8202	6857,5606	SYT1,MAP2K3
R-HSA-1483249	Inositol phosphate metabolism	0.526954018297062	-0.640641986055666	46	3	0.00609756097560976	492	8202	23236,8867,3628	PLCB1,SYNJ1,INPP1
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.528612215944767	-0.637500167081313	198	12	0.024390243902439	492	8202	3667,57761,2254,4893,6464,2308,2247,5682,4793,2260,27327,6199	IRS1,TRIB3,FGF9,NRAS,SHC1,FOXO1,FGF2,PSMA1,NFKBIB,FGFR1,TNRC6A,RPS6KB2
R-HSA-5663220	RHO GTPases Activate Formins	0.530746907453545	-0.63347000516366	114	7	0.0142276422764228	492	8202	348995,51466,71,23279,114793,401541,8379	NUP43,EVL,ACTG1,NUP160,FMNL2,CENPP,MAD1L1
R-HSA-1474244	Extracellular matrix organization	0.539602892724555	-0.616921793794567	267	16	0.032520325203252	492	8202	3910,1308,2335,2247,5578,667,4316,1462,3673,4323,8754,652,960,3691,4325,3911	LAMA4,COL17A1,FN1,FGF2,PRKCA,DST,MMP7,VCAN,ITGA2,MMP14,ADAM9,BMP4,CD44,ITGB4,MMP16,LAMA5
R-HSA-189200	Hexose transport	0.5416875367508	-0.613065944242554	47	3	0.00609756097560976	492	8202	348995,23279,3099	NUP43,NUP160,HK2
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.5416875367508	-0.613065944242554	47	3	0.00609756097560976	492	8202	6907,7090,55534	TBL1X,TLE3,MAML3
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.544813508162478	-0.607311729736013	30	2	0.0040650406504065	492	8202	9252,4208	RPS6KA5,MEF2C
R-HSA-420092	Glucagon-type ligand receptors	0.544813508162478	-0.607311729736013	30	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-68874	M/G1 Transition	0.551018826327635	-0.595986302849154	82	5	0.0101626016260163	492	8202	5682,4175,55388,4171,4174	PSMA1,MCM6,MCM10,MCM2,MCM5
R-HSA-69002	DNA Replication Pre-Initiation	0.551018826327635	-0.595986302849154	82	5	0.0101626016260163	492	8202	5682,4175,55388,4171,4174	PSMA1,MCM6,MCM10,MCM2,MCM5
R-HSA-1280215	Cytokine Signaling in Immune system	0.552747066879268	-0.592854765673372	539	32	0.0650406504065041	492	8202	200734,673,2335,5786,348995,23279,329,2317,5771,6464,8651,9020,960,7414,6709,2254,4893,3460,8831,2247,5908,1742,5682,3570,7324,2260,9636,3667,817,3836,7187,10581	SPRED2,BRAF,FN1,PTPRA,NUP43,NUP160,BIRC2,FLNB,PTPN2,SHC1,SOCS1,MAP3K14,CD44,VCL,SPTAN1,FGF9,NRAS,IFNGR2,SYNGAP1,FGF2,RAP1B,DLG4,PSMA1,IL6R,UBE2E1,FGFR1,ISG15,IRS1,CAMK2D,KPNA1,TRAF3,IFITM2
R-HSA-1502540	Signaling by Activin	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	4088	SMAD3
R-HSA-211227	Activation of DNA fragmentation factor	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	3836	KPNA1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	1803	DPP4
R-HSA-350054	Notch-HLH transcription pathway	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	55534	MAML3
R-HSA-174403	Glutathione synthesis and recycling	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	2678	GGT1
R-HSA-5210891	Uptake and function of anthrax toxins	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	5606	MAP2K3
R-HSA-171007	p38MAPK events	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	4893	NRAS
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	783	CACNB2
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	7112	TMPO
R-HSA-140342	Apoptosis induced DNA fragmentation	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	3836	KPNA1
R-HSA-2995410	Nuclear Envelope Reassembly	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	7112	TMPO
R-HSA-5626467	RHO GTPases activate IQGAPs	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	10788	IQGAP2
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	8935	SKAP2
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	57019	CIAPIN1
R-HSA-75892	Platelet Adhesion to exposed collagen	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	3673	ITGA2
R-HSA-1483213	Synthesis of PE	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	9663	LPIN2
R-HSA-177504	Retrograde neurotrophin signalling	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	26052	DNM3
R-HSA-1663150	The activation of arylsulfatases	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	79642	ARSJ
R-HSA-175474	Assembly Of The HIV Virion	0.552816120318216	-0.592729845741454	13	1	0.00203252032520325	492	8202	79720	VPS37B
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.556153143849864	-0.586711584078904	48	3	0.00609756097560976	492	8202	54331,6464,2787	GNG2,SHC1,GNG5
R-HSA-1296065	Inwardly rectifying K+ channels	0.562801664410796	-0.574827996371017	31	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.562801664410796	-0.574827996371017	31	2	0.0040650406504065	492	8202	4088,4092	SMAD3,SMAD7
R-HSA-180746	Nuclear import of Rev protein	0.562801664410796	-0.574827996371017	31	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.569915224248448	-0.562267658603542	101	6	0.0121951219512195	492	8202	6566,23516,30061,861,7922,148867	SLC16A1,SLC39A14,SLC40A1,RUNX1,SLC39A7,SLC30A7
R-HSA-112316	Neuronal System	0.570382980646423	-0.561447247903597	289	17	0.0345528455284553	492	8202	673,3786,81539,1742,23416,5578,6857,23236,2770,54331,2744,817,783,10550,54407,2787,5567	BRAF,KCNQ3,SLC38A1,DLG4,KCNH3,PRKCA,SYT1,PLCB1,GNAI1,GNG2,GLS,CAMK2D,CACNB2,ARL6IP5,SLC38A2,GNG5,PRKACB
R-HSA-5658442	Regulation of RAS by GAPs	0.577170384789419	-0.549617761802383	67	4	0.00813008130081301	492	8202	5682,200734,4893,8831	PSMA1,SPRED2,NRAS,SYNGAP1
R-HSA-68867	Assembly of the pre-replicative complex	0.577170384789419	-0.549617761802383	67	4	0.00813008130081301	492	8202	5682,4175,4171,4174	PSMA1,MCM6,MCM2,MCM5
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	4292	MLH1
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	6916	TBXAS1
R-HSA-3371568	Attenuation phase	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	3304	HSPA1B
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	10274	STAG1
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	4292	MLH1
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	2770	GNAI1
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	80270	HSD3B7
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	8829	NRP1
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	2770	GNAI1
R-HSA-418885	DCC mediated attractive signaling	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	7204	TRIO
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	7187	TRAF3
R-HSA-5682910	LGI-ADAM interactions	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	1742	DLG4
R-HSA-5675482	Regulation of necroptotic cell death	0.579683194286707	-0.545273541419441	14	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-202433	Generation of second messenger molecules	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	55740,51466	ENAH,EVL
R-HSA-1980145	Signaling by NOTCH2	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	182,55534	JAG1,MAML3
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	54331,2787	GNG2,GNG5
R-HSA-389356	CD28 co-stimulation	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	57761,9020	TRIB3,MAP3K14
R-HSA-376176	Signaling by Robo receptor	0.580274751645015	-0.544253577873922	32	2	0.0040650406504065	492	8202	55740,51466	ENAH,EVL
R-HSA-429914	Deadenylation-dependent mRNA decay	0.58424832015892	-0.537429180776683	50	3	0.00609756097560976	492	8202	85456,5073,26986	TNKS1BP1,PARN,PABPC1
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.58424832015892	-0.537429180776683	50	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-597592	Post-translational protein modification	0.586724230467175	-0.53320036431701	411	24	0.0487804878048781	492	8202	8924,57188,10274,9871,5283,22955,6612,348995,672,79642,23279,8869,6015,4758,4121,1912,149111,286053,197370,54872,89978,55568,648,7518	HERC2,ADAMTSL3,STAG1,SEC24D,PIGH,SCMH1,SUMO3,NUP43,BRCA1,ARSJ,NUP160,ST3GAL5,RING1,NEU1,MAN1A1,PHC2,CNIH3,NSMCE2,NSMCE1,PIGG,DPH6,GALNT10,BMI1,XRCC4
R-HSA-4085001	Sialic acid metabolism	0.597229724274085	-0.515453441826177	33	2	0.0040650406504065	492	8202	8869,4758	ST3GAL5,NEU1
R-HSA-5694530	Cargo concentration in the ER	0.597229724274085	-0.515453441826177	33	2	0.0040650406504065	492	8202	149111,9871	CNIH3,SEC24D
R-HSA-383280	Nuclear Receptor transcription pathway	0.597864686266974	-0.51439082778157	51	3	0.00609756097560976	492	8202	5468,2649,7025	PPARG,NR6A1,NR2F1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.597864686266974	-0.51439082778157	51	3	0.00609756097560976	492	8202	3373,50515,1462	HYAL1,CHST11,VCAN
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.597864686266974	-0.51439082778157	51	3	0.00609756097560976	492	8202	50807,200894,60412	ASAP1,ARL13B,EXOC4
R-HSA-449147	Signaling by Interleukins	0.59882792457889	-0.512780993290722	311	18	0.0365853658536585	492	8202	2254,200734,673,4893,2335,8831,2247,5786,5908,5682,1742,3570,2260,3667,817,6464,7414,6709	FGF9,SPRED2,BRAF,NRAS,FN1,SYNGAP1,FGF2,PTPRA,RAP1B,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	80270	HSD3B7
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	5533	PPP3CC
R-HSA-159418	Recycling of bile acids and salts	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	8714	ABCC3
R-HSA-549132	Organic cation/anion/zwitterion transport	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	861	RUNX1
R-HSA-194223	HDL-mediated lipid transport	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	949	SCARB1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	22943	DKK1
R-HSA-5358508	Mismatch Repair	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	4292	MLH1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.604939162582156	-0.502627383723006	15	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.608369344665916	-0.496973106674616	105	6	0.0121951219512195	492	8202	10919,1021,1019,7324,79813,10393	EHMT2,CDK6,CDK4,UBE2E1,EHMT1,ANAPC10
R-HSA-194315	Signaling by Rho GTPases	0.61166654687993	-0.491568002998222	399	23	0.0467479674796748	492	8202	23092,51466,71,3798,7204,1742,84033,23365,348995,9743,100288637,23279,5881,23028,401541,10788,58480,93663,8379,94134,101928168,114793,23081	ARHGAP26,EVL,ACTG1,KIF5A,TRIO,DLG4,OBSCN,ARHGEF12,NUP43,ARHGAP32,LOC100288637,NUP160,RAC3,KDM1A,CENPP,IQGAP2,RHOU,ARHGAP18,MAD1L1,ARHGAP12,LOC101928168,FMNL2,KDM4C
R-HSA-68949	Orc1 removal from chromatin	0.612224582268726	-0.49065609929343	70	4	0.00813008130081301	492	8202	5682,4175,4171,4174	PSMA1,MCM6,MCM2,MCM5
R-HSA-69052	Switching of origins to a post-replicative state	0.612224582268726	-0.49065609929343	70	4	0.00813008130081301	492	8202	5682,4175,4171,4174	PSMA1,MCM6,MCM2,MCM5
R-HSA-421837	Clathrin derived vesicle budding	0.612224582268726	-0.49065609929343	70	4	0.00813008130081301	492	8202	25977,27243,162,8907	NECAP1,CHMP2A,AP1B1,AP1M1
R-HSA-69473	G2/M DNA damage checkpoint	0.612224582268726	-0.49065609929343	70	4	0.00813008130081301	492	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.612224582268726	-0.49065609929343	70	4	0.00813008130081301	492	8202	25977,27243,162,8907	NECAP1,CHMP2A,AP1B1,AP1M1
R-HSA-1630316	Glycosaminoglycan metabolism	0.612423070476146	-0.490331943674116	123	7	0.0142276422764228	492	8202	3373,50515,960,3038,57214,1462,9653	HYAL1,CHST11,CD44,HAS3,CEMIP,VCAN,HS2ST1
R-HSA-212436	Generic Transcription Pathway	0.613502941059886	-0.488570220939017	553	32	0.0650406504065041	492	8202	9534,51123,4092,54541,54807,93134,7586,374655,7551,10794,55534,171392,10780,80205,7678,7748,2649,5468,340252,147657,57677,7025,2744,6498,7562,4088,28996,51586,80818,6834,80264,6907	ZNF254,ZNF706,SMAD7,DDIT4,ZNF586,ZNF561,ZKSCAN1,ZNF710,ZNF3,ZNF460,MAML3,ZNF675,ZNF234,CHD9,ZNF124,ZNF195,NR6A1,PPARG,ZNF680,ZNF480,ZFP14,NR2F1,GLS,SKIL,ZNF708,SMAD3,HIPK2,MED15,ZNF436,SURF1,ZNF430,TBL1X
R-HSA-177243	Interactions of Rev with host cellular proteins	0.613665750528861	-0.488304879309873	34	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-5687128	MAPK6/MAPK4 signaling	0.614642106245411	-0.486715121633413	88	5	0.0101626016260163	492	8202	5682,10435,2308,5567,27327	PSMA1,CDC42EP2,FOXO1,PRKACB,TNRC6A
R-HSA-1640170	Cell Cycle	0.621684584774989	-0.475322413293344	572	33	0.0670731707317073	492	8202	8924,4175,114799,55388,348995,4292,5578,23279,54386,9577,10783,4174,9663,10393,8379,4438,1021,7112,5984,5983,10274,328,7846,1019,7156,5682,672,4171,7324,401541,1778,10806,472	HERC2,MCM6,ESCO1,MCM10,NUP43,MLH1,PRKCA,NUP160,TERF2IP,BRE,NEK6,MCM5,LPIN2,ANAPC10,MAD1L1,MSH4,CDK6,TMPO,RFC4,RFC3,STAG1,APEX1,TUBA1A,CDK4,TOP3A,PSMA1,BRCA1,MCM2,UBE2E1,CENPP,DYNC1H1,SDCCAG8,ATM
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.624721044050994	-0.470450058398813	89	5	0.0101626016260163	492	8202	4793,9252,8411,5606,4208	NFKBIB,RPS6KA5,EEA1,MAP2K3,MEF2C
R-HSA-109581	Apoptosis	0.628022642251755	-0.465179058622877	160	9	0.0182926829268293	492	8202	3836,5366,5682,5533,7431,317,329,4137,6709	KPNA1,PMAIP1,PSMA1,PPP3CC,VIM,APAF1,BIRC2,MAPT,SPTAN1
R-HSA-1482922	Acyl chain remodelling of PI	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	81579	PLA2G12A
R-HSA-399956	CRMPs in Sema3A signaling	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	8829	NRP1
R-HSA-1295596	Spry regulation of FGF signaling	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	673	BRAF
R-HSA-5218859	Regulated Necrosis	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-5625900	RHO GTPases activate CIT	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	1742	DLG4
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	7048	TGFBR2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	8829	NRP1
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-69183	Processive synthesis on the lagging strand	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	328	APEX1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.628680451452414	-0.464132177678551	16	1	0.00203252032520325	492	8202	10347	ABCA7
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.629583958775554	-0.462696060641335	35	2	0.0040650406504065	492	8202	5451,10302	POU2F1,SNAPC5
R-HSA-194068	Bile acid and bile salt metabolism	0.629583958775554	-0.462696060641335	35	2	0.0040650406504065	492	8202	8714,80270	ABCC3,HSD3B7
R-HSA-1980143	Signaling by NOTCH1	0.634572473441169	-0.454803777008976	72	4	0.00813008130081301	492	8202	6907,182,7090,55534	TBL1X,JAG1,TLE3,MAML3
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.636932173817782	-0.451092106602212	54	3	0.00609756097560976	492	8202	667,4316,3691	DST,MMP7,ITGB4
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.636932173817782	-0.451092106602212	54	3	0.00609756097560976	492	8202	2965,2967,27339	GTF2H1,GTF2H3,PRPF19
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.636932173817782	-0.451092106602212	54	3	0.00609756097560976	492	8202	22916,348995,23279	NCBP2,NUP43,NUP160
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.636932173817782	-0.451092106602212	54	3	0.00609756097560976	492	8202	25977,162,8907	NECAP1,AP1B1,AP1M1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.644987206281129	-0.43852479760614	36	2	0.0040650406504065	492	8202	89978,79642	DPH6,ARSJ
R-HSA-5617833	Assembly of the primary cilium	0.645612693363631	-0.437555500875765	180	10	0.0203252032520325	492	8202	1778,55081,7846,57539,50807,10806,200894,60412,54903,79659	DYNC1H1,IFT57,TUBA1A,WDR35,ASAP1,SDCCAG8,ARL13B,EXOC4,MKS1,DYNC2H1
R-HSA-2142753	Arachidonic acid metabolism	0.649350680477279	-0.43178236849053	55	3	0.00609756097560976	492	8202	2678,1800,6916	GGT1,DPEP1,TBXAS1
R-HSA-977443	GABA receptor activation	0.649350680477279	-0.43178236849053	55	3	0.00609756097560976	492	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.649350680477279	-0.43178236849053	55	3	0.00609756097560976	492	8202	5682,26986,3304	PSMA1,PABPC1,HSPA1B
R-HSA-5357801	Programmed Cell Death	0.650165471115385	-0.430528377543393	163	9	0.0182926829268293	492	8202	3836,5366,5682,5533,7431,317,329,4137,6709	KPNA1,PMAIP1,PSMA1,PPP3CC,VIM,APAF1,BIRC2,MAPT,SPTAN1
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.650997727043496	-0.429249128264309	17	1	0.00203252032520325	492	8202	5606	MAP2K3
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.650997727043496	-0.429249128264309	17	1	0.00203252032520325	492	8202	677	ZFP36L1
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.650997727043496	-0.429249128264309	17	1	0.00203252032520325	492	8202	5073	PARN
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.650997727043496	-0.429249128264309	17	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.650997727043496	-0.429249128264309	17	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-1852241	Organelle biogenesis and maintenance	0.653059009453467	-0.426087787091031	321	18	0.0365853658536585	492	8202	80205,55081,7846,133522,54903,92399,55173,4209,1778,57539,50807,200894,10806,23107,60412,79659,6907,4208	CHD9,IFT57,TUBA1A,PPARGC1B,MKS1,MRRF,MRPS10,MEF2D,DYNC1H1,WDR35,ASAP1,ARL13B,SDCCAG8,MRPS27,EXOC4,DYNC2H1,TBL1X,MEF2C
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.653992457489992	-0.424659460481363	92	5	0.0101626016260163	492	8202	4793,8651,9252,5606,4208	NFKBIB,SOCS1,RPS6KA5,MAP2K3,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.653992457489992	-0.424659460481363	92	5	0.0101626016260163	492	8202	4793,8651,9252,5606,4208	NFKBIB,SOCS1,RPS6KA5,MAP2K3,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.653992457489992	-0.424659460481363	92	5	0.0101626016260163	492	8202	4793,8651,9252,5606,4208	NFKBIB,SOCS1,RPS6KA5,MAP2K3,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.653992457489992	-0.424659460481363	92	5	0.0101626016260163	492	8202	4793,8651,9252,5606,4208	NFKBIB,SOCS1,RPS6KA5,MAP2K3,MEF2C
R-HSA-877300	Interferon gamma signaling	0.653992457489992	-0.424659460481363	92	5	0.0101626016260163	492	8202	5771,817,960,8651,3460	PTPN2,CAMK2D,CD44,SOCS1,IFNGR2
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.656072679654459	-0.421483704018858	74	4	0.00813008130081301	492	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-419037	NCAM1 interactions	0.659879868571859	-0.415697477844192	37	2	0.0040650406504065	492	8202	783,8912	CACNB2,CACNA1H
R-HSA-5693606	DNA Double Strand Break Response	0.666499286959514	-0.405716209192132	75	4	0.00813008130081301	492	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.671976238736233	-0.397532298107596	18	1	0.00203252032520325	492	8202	1523	CUX1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.671976238736233	-0.397532298107596	18	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.671976238736233	-0.397532298107596	18	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-156584	Cytosolic sulfonation of small molecules	0.671976238736233	-0.397532298107596	18	1	0.00203252032520325	492	8202	6819	SULT1C2
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.671976238736233	-0.397532298107596	18	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.673272460764398	-0.395605186147106	57	3	0.00609756097560976	492	8202	6907,182,55534	TBL1X,JAG1,MAML3
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.673272460764398	-0.395605186147106	57	3	0.00609756097560976	492	8202	6907,182,55534	TBL1X,JAG1,MAML3
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.673272460764398	-0.395605186147106	57	3	0.00609756097560976	492	8202	6907,182,55534	TBL1X,JAG1,MAML3
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.673272460764398	-0.395605186147106	57	3	0.00609756097560976	492	8202	6907,182,55534	TBL1X,JAG1,MAML3
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.673272460764398	-0.395605186147106	57	3	0.00609756097560976	492	8202	6907,182,55534	TBL1X,JAG1,MAML3
R-HSA-69236	G1 Phase	0.674267647617205	-0.394128143604852	38	2	0.0040650406504065	492	8202	1021,1019	CDK6,CDK4
R-HSA-69231	Cyclin D associated events in G1	0.674267647617205	-0.394128143604852	38	2	0.0040650406504065	492	8202	1021,1019	CDK6,CDK4
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.686698306068581	-0.375860230129219	77	4	0.00813008130081301	492	8202	54386,472,8091,57634	TERF2IP,ATM,HMGA2,EP400
R-HSA-416700	Other semaphorin interactions	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	57556	SEMA6A
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-1181150	Signaling by NODAL	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	4088	SMAD3
R-HSA-71403	Citric acid cycle (TCA cycle)	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	8802	SUCLG1
R-HSA-3928664	Ephrin signaling	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	1948	EFNB2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.691696142272763	-0.36860852055934	19	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-157579	Telomere Maintenance	0.696469103936389	-0.361731845775042	78	4	0.00813008130081301	492	8202	54386,5984,5983,328	TERF2IP,RFC4,RFC3,APEX1
R-HSA-5675221	Negative regulation of MAPK pathway	0.701556967092981	-0.354453175191542	40	2	0.0040650406504065	492	8202	673,4893	BRAF,NRAS
R-HSA-1660662	Glycosphingolipid metabolism	0.701556967092981	-0.354453175191542	40	2	0.0040650406504065	492	8202	79642,4758	ARSJ,NEU1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.706868792591602	-0.346910213629917	60	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-450294	MAP kinase activation in TLR cascade	0.706868792591602	-0.346910213629917	60	3	0.00609756097560976	492	8202	9252,5606,4208	RPS6KA5,MAP2K3,MEF2C
R-HSA-73923	Lipid digestion, mobilization, and transport	0.706868792591602	-0.346910213629917	60	3	0.00609756097560976	492	8202	949,11343,5567	SCARB1,MGLL,PRKACB
R-HSA-453279	Mitotic G1-G1/S phases	0.708257441949098	-0.344947632809456	135	7	0.0142276422764228	492	8202	5682,4175,55388,4171,4174,1021,1019	PSMA1,MCM6,MCM10,MCM2,MCM5,CDK6,CDK4
R-HSA-5358351	Signaling by Hedgehog	0.708257441949098	-0.344947632809456	135	7	0.0142276422764228	492	8202	5682,55081,79659,57539,5576,5567,54903	PSMA1,IFT57,DYNC2H1,WDR35,PRKAR2A,PRKACB,MKS1
R-HSA-1483191	Synthesis of PC	0.710232803397616	-0.342162470582327	20	1	0.00203252032520325	492	8202	9663	LPIN2
R-HSA-210745	Regulation of gene expression in beta cells	0.710232803397616	-0.342162470582327	20	1	0.00203252032520325	492	8202	2308	FOXO1
R-HSA-68882	Mitotic Anaphase	0.71191280712457	-0.339799836972926	172	9	0.0182926829268293	492	8202	10274,10393,8379,5682,348995,23279,7324,7112,401541	STAG1,ANAPC10,MAD1L1,PSMA1,NUP43,NUP160,UBE2E1,TMPO,CENPP
R-HSA-168325	Viral Messenger RNA Synthesis	0.71447505485909	-0.336207194945136	41	2	0.0040650406504065	492	8202	348995,23279	NUP43,NUP160
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.717462739654815	-0.332034263491494	61	3	0.00609756097560976	492	8202	84033,23365,7204	OBSCN,ARHGEF12,TRIO
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.718318705048875	-0.330841929520853	173	9	0.0182926829268293	492	8202	10274,10393,8379,5682,348995,23279,7324,7112,401541	STAG1,ANAPC10,MAD1L1,PSMA1,NUP43,NUP160,UBE2E1,TMPO,CENPP
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.724649937773246	-0.322066585185076	100	5	0.0101626016260163	492	8202	348995,10274,23279,401541,8379	NUP43,STAG1,NUP160,CENPP,MAD1L1
R-HSA-3928662	EPHB-mediated forward signaling	0.726921080794991	-0.318937361955964	42	2	0.0040650406504065	492	8202	1948,71	EFNB2,ACTG1
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	55824	PAG1
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-4641263	Regulation of FZD by ubiquitination	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	54894	RNF43
R-HSA-390918	Peroxisomal lipid metabolism	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	51	ACOX1
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	5646	PRSS3
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.727657083633996	-0.317925380723445	21	1	0.00203252032520325	492	8202	204	AK2
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.733359653891463	-0.310119037277753	82	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.733359653891463	-0.310119037277753	82	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-193704	p75 NTR receptor-mediated signalling	0.733359653891463	-0.310119037277753	82	4	0.00813008130081301	492	8202	84033,57142,23365,7204	OBSCN,RTN4,ARHGEF12,TRIO
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.733359653891463	-0.310119037277753	82	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.737757134869952	-0.304140594084265	63	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.737757134869952	-0.304140594084265	63	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-1296072	Voltage gated Potassium channels	0.738905068106586	-0.30258582622258	43	2	0.0040650406504065	492	8202	23416,3786	KCNH3,KCNQ3
R-HSA-382551	Transmembrane transport of small molecules	0.740927782500573	-0.299852117948934	586	32	0.0650406504065041	492	8202	348995,3163,23279,51076,10347,148867,23657,7922,54407,57719,2787,5567,30061,6520,81539,6262,535,1244,10110,28982,6553,374868,6541,23516,54331,3099,9497,6566,8714,861,5576,8501	NUP43,HMOX2,NUP160,CUTC,ABCA7,SLC30A7,SLC7A11,SLC39A7,SLC38A2,ANO8,GNG5,PRKACB,SLC40A1,SLC3A2,SLC38A1,RYR2,ATP6V0A1,ABCC2,SGK2,FLVCR1,SLC9A5,ATP9B,SLC7A1,SLC39A14,GNG2,HK2,SLC4A7,SLC16A1,ABCC3,RUNX1,PRKAR2A,SLC43A1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.742037244428345	-0.298355842427101	83	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.744035608843172	-0.295666383946013	22	1	0.00203252032520325	492	8202	9140	ATG12
R-HSA-203765	eNOS activation and regulation	0.744035608843172	-0.295666383946013	22	1	0.00203252032520325	492	8202	115677	NOSTRIN
R-HSA-5205647	Mitophagy	0.744035608843172	-0.295666383946013	22	1	0.00203252032520325	492	8202	9140	ATG12
R-HSA-202131	Metabolism of nitric oxide	0.744035608843172	-0.295666383946013	22	1	0.00203252032520325	492	8202	115677	NOSTRIN
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.747463757954938	-0.291069459233919	64	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-5362517	Signaling by Retinoic Acid	0.750437537477579	-0.287098859250228	44	2	0.0040650406504065	492	8202	1374,157506	CPT1A,RDH10
R-HSA-351202	Metabolism of polyamines	0.750499110973153	-0.287016812488731	84	4	0.00813008130081301	492	8202	5682,6723,6535,4953	PSMA1,SRM,SLC6A8,ODC1
R-HSA-2467813	Separation of Sister Chromatids	0.758118331405816	-0.27691579548961	161	8	0.016260162601626	492	8202	10274,10393,8379,5682,348995,23279,7324,401541	STAG1,ANAPC10,MAD1L1,PSMA1,NUP43,NUP160,UBE2E1,CENPP
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.758746869344777	-0.276087062686428	85	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.758746869344777	-0.276087062686428	85	4	0.00813008130081301	492	8202	4793,9252,5606,4208	NFKBIB,RPS6KA5,MAP2K3,MEF2C
R-HSA-73980	RNA Polymerase III Transcription Termination	0.759431022106271	-0.275185781207283	23	1	0.00203252032520325	492	8202	4774	NFIA
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.759431022106271	-0.275185781207283	23	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-112409	RAF-independent MAPK1/3 activation	0.759431022106271	-0.275185781207283	23	1	0.00203252032520325	492	8202	3570	IL6R
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.759431022106271	-0.275185781207283	23	1	0.00203252032520325	492	8202	6857	SYT1
R-HSA-201451	Signaling by BMP	0.759431022106271	-0.275185781207283	23	1	0.00203252032520325	492	8202	4092	SMAD7
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.761529411657013	-0.272426484074314	45	2	0.0040650406504065	492	8202	27327,55534	TNRC6A,MAML3
R-HSA-73886	Chromosome Maintenance	0.763230076608572	-0.270195751070349	105	5	0.0101626016260163	492	8202	54386,5984,5983,328,401541	TERF2IP,RFC4,RFC3,APEX1,CENPP
R-HSA-1474290	Collagen formation	0.766782372429079	-0.265552256560699	86	4	0.00813008130081301	492	8202	667,1308,4316,3691	DST,COL17A1,MMP7,ITGB4
R-HSA-168249	Innate Immune System	0.768517632683625	-0.263291771980919	752	41	0.0833333333333333	492	8202	200734,26052,673,2335,2308,71,5786,5646,5578,9252,329,8411,5606,6464,8651,10010,9020,7414,5567,843,6709,6199,2254,4893,8831,2247,5908,5682,1742,9140,3093,9636,2260,3667,817,57761,7187,4793,5576,27327,4208	SPRED2,DNM3,BRAF,FN1,FOXO1,ACTG1,PTPRA,PRSS3,PRKCA,RPS6KA5,BIRC2,EEA1,MAP2K3,SHC1,SOCS1,TANK,MAP3K14,VCL,PRKACB,CASP10,SPTAN1,RPS6KB2,FGF9,NRAS,SYNGAP1,FGF2,RAP1B,PSMA1,DLG4,ATG12,UBE2K,ISG15,FGFR1,IRS1,CAMK2D,TRIB3,TRAF3,NFKBIB,PRKAR2A,TNRC6A,MEF2C
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.77043534984843	-0.260799534493237	106	5	0.0101626016260163	492	8202	9887,22916,26019,6158,26986	SMG7,NCBP2,UPF2,RPL28,PABPC1
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.77043534984843	-0.260799534493237	106	5	0.0101626016260163	492	8202	9887,22916,26019,6158,26986	SMG7,NCBP2,UPF2,RPL28,PABPC1
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.772191929538744	-0.258522146464394	46	2	0.0040650406504065	492	8202	6576,26027	SLC25A1,ACOT11
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	23365	ARHGEF12
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	9871	SEC24D
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-933542	TRAF6 mediated NF-kB activation	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	80270	HSD3B7
R-HSA-5365859	RA biosynthesis pathway	0.773902221161308	-0.256309742621578	24	1	0.00203252032520325	492	8202	157506	RDH10
R-HSA-373080	Class B/2 (Secretin family receptors)	0.774607691907756	-0.255398581783275	87	4	0.00813008130081301	492	8202	54331,51384,2787,7976	GNG2,WNT16,GNG5,FZD3
R-HSA-216083	Integrin cell surface interactions	0.774866190766082	-0.255064921611762	67	3	0.00609756097560976	492	8202	2335,960,3673	FN1,CD44,ITGA2
R-HSA-373755	Semaphorin interactions	0.774866190766082	-0.255064921611762	67	3	0.00609756097560976	492	8202	23365,8829,57556	ARHGEF12,NRP1,SEMA6A
R-HSA-1632852	Macroautophagy	0.774866190766082	-0.255064921611762	67	3	0.00609756097560976	492	8202	9140,27243,92421	ATG12,CHMP2A,CHMP4C
R-HSA-162909	Host Interactions of HIV factors	0.781839942105307	-0.246105237000845	127	6	0.0121951219512195	492	8202	5682,348995,3836,162,23279,8907	PSMA1,NUP43,KPNA1,AP1B1,NUP160,AP1M1
R-HSA-909733	Interferon alpha/beta signaling	0.783442137801894	-0.244058070836093	68	3	0.00609756097560976	492	8202	8651,10581,9636	SOCS1,IFITM2,ISG15
R-HSA-68877	Mitotic Prometaphase	0.784343662988821	-0.242908009028111	108	5	0.0101626016260163	492	8202	348995,10274,23279,401541,8379	NUP43,STAG1,NUP160,CENPP,MAD1L1
R-HSA-69278	Cell Cycle, Mitotic	0.790689327801203	-0.234850147149242	477	25	0.0508130081300813	492	8202	5984,4175,114799,5983,55388,7846,328,10274,1019,5682,348995,4171,5578,23279,7324,401541,1778,10783,4174,10806,9663,10393,8379,1021,7112	RFC4,MCM6,ESCO1,RFC3,MCM10,TUBA1A,APEX1,STAG1,CDK4,PSMA1,NUP43,MCM2,PRKCA,NUP160,UBE2E1,CENPP,DYNC1H1,NEK6,MCM5,SDCCAG8,LPIN2,ANAPC10,MAD1L1,CDK6,TMPO
R-HSA-69206	G1/S Transition	0.791049516625976	-0.234394713140944	109	5	0.0101626016260163	492	8202	5682,4175,55388,4171,4174	PSMA1,MCM6,MCM10,MCM2,MCM5
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.791059958549805	-0.23438151313931	223	11	0.0223577235772358	492	8202	8924,8651,57630,10393,51444,5682,26046,90678,3093,23352,7324	HERC2,SOCS1,SH3RF1,ANAPC10,RNF138,PSMA1,LTN1,LRSAM1,UBE2K,UBR4,UBE2E1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.791746769742156	-0.233513673467945	69	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.791746769742156	-0.233513673467945	69	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-73887	Death Receptor Signalling	0.79227497901132	-0.232846751704835	48	2	0.0040650406504065	492	8202	329,843	BIRC2,CASP10
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.796846184360866	-0.227093612091214	90	4	0.00813008130081301	492	8202	1778,7846,10806,54903	DYNC1H1,TUBA1A,SDCCAG8,MKS1
R-HSA-157118	Signaling by NOTCH	0.797591931038675	-0.226158176936991	110	5	0.0101626016260163	492	8202	6907,182,7090,27327,55534	TBL1X,JAG1,TLE3,TNRC6A,MAML3
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.7997850766505	-0.223412241595086	70	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-3781865	Diseases of glycosylation	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-912694	Regulation of IFNA signaling	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	8651	SOCS1
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	1462	VCAN
R-HSA-77387	Insulin receptor recycling	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	535	ATP6V0A1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.800290169133505	-0.222780905661212	26	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-936837	Ion transport by P-type ATPases	0.80171891590979	-0.220997211463185	49	2	0.0040650406504065	492	8202	51076,374868	CUTC,ATP9B
R-HSA-4086400	PCP/CE pathway	0.803855263118687	-0.218336047005553	91	4	0.00813008130081301	492	8202	5682,5578,5881,7976	PSMA1,PRKCA,RAC3,FZD3
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.810780190747403	-0.209758296440045	50	2	0.0040650406504065	492	8202	5682,1019	PSMA1,CDK4
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.810780190747403	-0.209758296440045	50	2	0.0040650406504065	492	8202	5682,1019	PSMA1,CDK4
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.810780190747403	-0.209758296440045	50	2	0.0040650406504065	492	8202	5682,4953	PSMA1,ODC1
R-HSA-392499	Metabolism of proteins	0.810802391940224	-0.209730914309699	943	51	0.103658536585366	492	8202	8924,9871,3798,4240,5283,8604,3800,348995,79642,6748,23279,5073,6015,4121,148867,1912,440,6464,149111,23203,54872,89978,2395,26986,7709,468,10274,7846,57188,617,22955,6612,672,8869,9709,6934,4758,10469,2627,6158,286053,197370,6730,60412,1803,55568,8891,648,7518,6727,1649	HERC2,SEC24D,KIF5A,MFGE8,PIGH,SLC25A12,KIF5C,NUP43,ARSJ,SSR4,NUP160,PARN,RING1,MAN1A1,SLC30A7,PHC2,ASNS,SHC1,CNIH3,PMPCA,PIGG,DPH6,FXN,PABPC1,ZBTB17,ATF4,STAG1,TUBA1A,ADAMTSL3,BCS1L,SCMH1,SUMO3,BRCA1,ST3GAL5,HERPUD1,TCF7L2,NEU1,TIMM44,GATA6,RPL28,NSMCE2,NSMCE1,SRP68,EXOC4,DPP4,GALNT10,EIF2B3,BMI1,XRCC4,SRP14,DDIT3
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.812307932921335	-0.207875782973489	27	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-192105	Synthesis of bile acids and bile salts	0.812307932921335	-0.207875782973489	27	1	0.00203252032520325	492	8202	80270	HSD3B7
R-HSA-400685	Sema4D in semaphorin signaling	0.812307932921335	-0.207875782973489	27	1	0.00203252032520325	492	8202	23365	ARHGEF12
R-HSA-416476	G alpha (q) signalling events	0.812803142040251	-0.207266336466264	190	9	0.0182926829268293	492	8202	54331,5583,221955,4923,7204,57406,11343,23236,2787	GNG2,PRKCH,DAGLB,NTSR1,TRIO,ABHD6,MGLL,PLCB1,GNG5
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.815083515120107	-0.204464698451217	72	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.819470619488287	-0.1990967331941	51	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-380287	Centrosome maturation	0.822354389504287	-0.195583846052326	73	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.822354389504287	-0.195583846052326	73	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.822354389504287	-0.195583846052326	73	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.822354389504287	-0.195583846052326	73	3	0.00609756097560976	492	8202	2744,54541,6834	GLS,DDIT4,SURF1
R-HSA-3700989	Transcriptional Regulation by TP53	0.822354389504287	-0.195583846052326	73	3	0.00609756097560976	492	8202	2744,54541,6834	GLS,DDIT4,SURF1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.823603895865604	-0.194065573551196	28	1	0.00203252032520325	492	8202	57761	TRIB3
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.823603895865604	-0.194065573551196	28	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.827801980317501	-0.188981307404721	52	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.827801980317501	-0.188981307404721	52	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-69541	Stabilization of p53	0.827801980317501	-0.188981307404721	52	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.827801980317501	-0.188981307404721	52	2	0.0040650406504065	492	8202	8869,4758	ST3GAL5,NEU1
R-HSA-69610	p53-Independent DNA Damage Response	0.827801980317501	-0.188981307404721	52	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-195721	Signaling by Wnt	0.832540143246128	-0.183273838174622	326	16	0.032520325203252	492	8202	7090,79971,7976,5682,54894,5578,6659,23236,5881,6934,22943,54331,51384,440193,2787,27327	TLE3,WLS,FZD3,PSMA1,RNF43,PRKCA,SOX4,PLCB1,RAC3,TCF7L2,DKK1,GNG2,WNT16,CCDC88C,GNG5,TNRC6A
R-HSA-68875	Mitotic Prophase	0.833412460440683	-0.182226608772841	136	6	0.0121951219512195	492	8202	348995,10783,5578,23279,9663,7112	NUP43,NEK6,PRKCA,NUP160,LPIN2,TMPO
R-HSA-917977	Transferrin endocytosis and recycling	0.834221327145666	-0.181256531559922	29	1	0.00203252032520325	492	8202	535	ATP6V0A1
R-HSA-381038	XBP1(S) activates chaperone genes	0.835785975633762	-0.179382708681053	53	2	0.0040650406504065	492	8202	7709,6464	ZBTB17,SHC1
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.836006035994856	-0.179119445833959	96	4	0.00813008130081301	492	8202	5682,7187,9020,329	PSMA1,TRAF3,MAP3K14,BIRC2
R-HSA-3214858	RMTs methylate histone arginines	0.836167089344622	-0.178926818231204	75	3	0.00609756097560976	492	8202	57492,317772,1019	ARID1B,HIST2H2AB,CDK4
R-HSA-1221632	Meiotic synapsis	0.836167089344622	-0.178926818231204	75	3	0.00609756097560976	492	8202	54386,672,10274	TERF2IP,BRCA1,STAG1
R-HSA-428157	Sphingolipid metabolism	0.842720195812115	-0.171120290889819	76	3	0.00609756097560976	492	8202	79642,4758,10087	ARSJ,NEU1,COL4A3BP
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.843434198780079	-0.170273389784048	54	2	0.0040650406504065	492	8202	1462,9653	VCAN,HS2ST1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.84420090710403	-0.169364771121132	30	1	0.00203252032520325	492	8202	182	JAG1
R-HSA-174824	Lipoprotein metabolism	0.84420090710403	-0.169364771121132	30	1	0.00203252032520325	492	8202	949	SCARB1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.84420090710403	-0.169364771121132	30	1	0.00203252032520325	492	8202	6464	SHC1
R-HSA-5683826	Surfactant metabolism	0.84420090710403	-0.169364771121132	30	1	0.00203252032520325	492	8202	2627	GATA6
R-HSA-2187338	Visual phototransduction	0.847576336055914	-0.165374371741398	98	4	0.00813008130081301	492	8202	5578,5947,157506,4647	PRKCA,RBP1,RDH10,MYO7A
R-HSA-156580	Phase II conjugation	0.847576336055914	-0.165374371741398	98	4	0.00813008130081301	492	8202	2678,2941,6819,4257	GGT1,GSTA4,SULT1C2,MGST1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.849045407543896	-0.16364261053927	77	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-381070	IRE1alpha activates chaperones	0.850758105134844	-0.161627438599964	55	2	0.0040650406504065	492	8202	7709,6464	ZBTB17,SHC1
R-HSA-1296071	Potassium Channels	0.853098774749893	-0.158879941301208	99	4	0.00813008130081301	492	8202	54331,23416,3786,2787	GNG2,KCNH3,KCNQ3,GNG5
R-HSA-2129379	Molecules associated with elastic fibres	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	652	BMP4
R-HSA-168638	NOD1/2 Signaling Pathway	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-418990	Adherens junctions interactions	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	25945	PVRL3
R-HSA-70171	Glycolysis	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	3099	HK2
R-HSA-5357905	Regulation of TNFR1 signaling	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-2022928	HS-GAG biosynthesis	0.853580881856965	-0.158314976320195	31	1	0.00203252032520325	492	8202	9653	HS2ST1
R-HSA-186712	Regulation of beta-cell development	0.862397208641299	-0.14803931556583	32	1	0.00203252032520325	492	8202	2308	FOXO1
R-HSA-168256	Immune System	0.862550628870627	-0.14786143165955	1371	74	0.150406504065041	492	8202	200734,26052,71,5786,3798,55740,348995,162,5578,23279,329,8411,55824,2317,5606,6464,8651,10393,8907,7414,5567,843,51466,4893,56992,1742,9140,535,23352,2260,1525,114876,817,57630,7187,27327,4208,8924,673,2335,2308,9871,5646,9252,10666,5771,10010,51164,26046,79659,960,9020,90678,6709,6199,2254,3460,8831,2247,11069,5908,5682,3570,3093,9636,7324,3667,1778,57761,3836,51444,10581,4793,5576	SPRED2,DNM3,ACTG1,PTPRA,KIF5A,ENAH,NUP43,AP1B1,PRKCA,NUP160,BIRC2,EEA1,PAG1,FLNB,MAP2K3,SHC1,SOCS1,ANAPC10,AP1M1,VCL,PRKACB,CASP10,EVL,NRAS,KIF15,DLG4,ATG12,ATP6V0A1,UBR4,FGFR1,CXADR,OSBPL1A,CAMK2D,SH3RF1,TRAF3,TNRC6A,MEF2C,HERC2,BRAF,FN1,FOXO1,SEC24D,PRSS3,RPS6KA5,CD226,PTPN2,TANK,DCTN4,LTN1,DYNC2H1,CD44,MAP3K14,LRSAM1,SPTAN1,RPS6KB2,FGF9,IFNGR2,SYNGAP1,FGF2,RAPGEF4,RAP1B,PSMA1,IL6R,UBE2K,ISG15,UBE2E1,IRS1,DYNC1H1,TRIB3,KPNA1,RNF138,IFITM2,NFKBIB,PRKAR2A
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.864477951478344	-0.145629478546851	57	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.864477951478344	-0.145629478546851	57	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-3214847	HATs acetylate histones	0.866376266297857	-0.143435977140258	143	6	0.0121951219512195	492	8202	57634,284058,23587,55689,317772,7994	EP400,KANSL1,ELP5,YEATS2,HIST2H2AB,KAT6A
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.866376266297857	-0.143435977140258	143	6	0.0121951219512195	492	8202	6566,2110,4725,8802,51660,6834	SLC16A1,ETFDH,NDUFS5,SUCLG1,MPC1,SURF1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.868679956184222	-0.140780511328581	123	5	0.0101626016260163	492	8202	5682,4893,9020,9252,5567	PSMA1,NRAS,MAP3K14,RPS6KA5,PRKACB
R-HSA-933541	TRAF6 mediated IRF7 activation	0.870683692527357	-0.138476522474956	33	1	0.00203252032520325	492	8202	10010	TANK
R-HSA-72187	mRNA 3'-end processing	0.870683692527357	-0.138476522474956	33	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.870895903045938	-0.138232823570616	58	2	0.0040650406504065	492	8202	5682,9020	PSMA1,MAP3K14
R-HSA-611105	Respiratory electron transport	0.872182058592103	-0.136757094076142	81	3	0.00609756097560976	492	8202	2110,4725,6834	ETFDH,NDUFS5,SURF1
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.872182058592103	-0.136757094076142	81	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.872182058592103	-0.136757094076142	81	3	0.00609756097560976	492	8202	5682,7090,6934	PSMA1,TLE3,TCF7L2
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.877033526823295	-0.131210058351729	59	2	0.0040650406504065	492	8202	5682,5567	PSMA1,PRKACB
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.877033526823295	-0.131210058351729	59	2	0.0040650406504065	492	8202	5682,5567	PSMA1,PRKACB
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.877033526823295	-0.131210058351729	59	2	0.0040650406504065	492	8202	5682,5567	PSMA1,PRKACB
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.877033526823295	-0.131210058351729	59	2	0.0040650406504065	492	8202	5682,9020	PSMA1,MAP3K14
R-HSA-1222556	ROS production in response to bacteria	0.878472115019461	-0.129571113441616	34	1	0.00203252032520325	492	8202	535	ATP6V0A1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.878472115019461	-0.129571113441616	34	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-72766	Translation	0.878752648004934	-0.129251822484922	146	6	0.0121951219512195	492	8202	6748,8891,6158,6730,6727,26986	SSR4,EIF2B3,RPL28,SRP68,SRP14,PABPC1
R-HSA-453276	Regulation of mitotic cell cycle	0.882531916136861	-0.124960325234467	83	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.882531916136861	-0.124960325234467	83	3	0.00609756097560976	492	8202	5682,7324,10393	PSMA1,UBE2E1,ANAPC10
R-HSA-168254	Influenza Infection	0.88265866399718	-0.1248167171029	147	6	0.0121951219512195	492	8202	348995,3836,6158,23279,9636,3304	NUP43,KPNA1,RPL28,NUP160,ISG15,HSPA1B
R-HSA-69615	G1/S DNA Damage Checkpoints	0.882901276289585	-0.124541889510366	60	2	0.0040650406504065	492	8202	5682,472	PSMA1,ATM
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.885350061358061	-0.12177216262618	267	12	0.024390243902439	492	8202	8924,8651,9871,57630,10393,51444,5682,26046,90678,3093,23352,7324	HERC2,SOCS1,SEC24D,SH3RF1,ANAPC10,RNF138,PSMA1,LTN1,LRSAM1,UBE2K,UBR4,UBE2E1
R-HSA-2514856	The phototransduction cascade	0.885792354908883	-0.12127271824954	35	1	0.00203252032520325	492	8202	5578	PRKCA
R-HSA-5419276	Mitochondrial translation termination	0.887422020033188	-0.119434626244237	84	3	0.00609756097560976	492	8202	92399,55173,23107	MRRF,MRPS10,MRPS27
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.888509362273503	-0.118210094275245	61	2	0.0040650406504065	492	8202	1591,6916	CYP24A1,TBXAS1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.891447993747279	-0.114908179053804	107	4	0.00813008130081301	492	8202	6748,6158,6730,6727	SSR4,RPL28,SRP68,SRP14
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.892672501989975	-0.113535504463838	36	1	0.00203252032520325	492	8202	71	ACTG1
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.892672501989975	-0.113535504463838	36	1	0.00203252032520325	492	8202	1591	CYP24A1
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.892672501989975	-0.113535504463838	36	1	0.00203252032520325	492	8202	10087	COL4A3BP
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.892672501989975	-0.113535504463838	36	1	0.00203252032520325	492	8202	6464	SHC1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.893867744565992	-0.112197451479418	62	2	0.0040650406504065	492	8202	22989,60412	MYH15,EXOC4
R-HSA-71291	Metabolism of amino acids and derivatives	0.896929465396669	-0.108778053909608	212	9	0.0182926829268293	492	8202	6723,2744,440,29968,5682,6535,5832,4953,5831	SRM,GLS,ASNS,PSAT1,PSMA1,SLC6A8,ALDH18A1,ODC1,PYCR1
R-HSA-4608870	Asymmetric localization of PCP proteins	0.898986125215149	-0.106487678205645	63	2	0.0040650406504065	492	8202	5682,7976	PSMA1,FZD3
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.903873943518282	-0.101065371323791	64	2	0.0040650406504065	492	8202	23028,23081	KDM1A,KDM4C
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.903929582134434	-0.10100381749299	153	6	0.0121951219512195	492	8202	10946,22916,2521,348995,23279,27339	SF3A3,NCBP2,FUS,NUP43,NUP160,PRPF19
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.905216567192265	-0.0995810631451384	38	1	0.00203252032520325	492	8202	10038	PARP2
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.909243713885097	-0.0951421086554649	89	3	0.00609756097560976	492	8202	22916,6158,26986	NCBP2,RPL28,PABPC1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.910928650604501	-0.0932907046526748	39	1	0.00203252032520325	492	8202	57188	ADAMTSL3
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.912994317387538	-0.0910256225165739	66	2	0.0040650406504065	492	8202	9871,149111	SEC24D,CNIH3
R-HSA-1169091	Activation of NF-kappaB in B cells	0.912994317387538	-0.0910256225165739	66	2	0.0040650406504065	492	8202	5682,4793	PSMA1,NFKBIB
R-HSA-5368287	Mitochondrial translation	0.913119490753903	-0.0908885298928794	90	3	0.00609756097560976	492	8202	92399,55173,23107	MRRF,MRPS10,MRPS27
R-HSA-72163	mRNA Splicing - Major Pathway	0.914168791187742	-0.0897400515060325	113	4	0.00813008130081301	492	8202	10946,22916,2521,27339	SF3A3,NCBP2,FUS,PRPF19
R-HSA-109703	PKB-mediated events	0.916297155296155	-0.0874145615708966	40	1	0.00203252032520325	492	8202	5140	PDE3B
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.916297155296155	-0.0874145615708966	40	1	0.00203252032520325	492	8202	949	SCARB1
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.917244413607254	-0.0863813061362333	67	2	0.0040650406504065	492	8202	8869,4758	ST3GAL5,NEU1
R-HSA-168255	Influenza Life Cycle	0.9174820157194	-0.0861223006412704	136	5	0.0101626016260163	492	8202	348995,3836,6158,23279,3304	NUP43,KPNA1,RPL28,NUP160,HSPA1B
R-HSA-202403	TCR signaling	0.920743205487993	-0.0825741030075748	115	4	0.00813008130081301	492	8202	5682,55740,51466,55824	PSMA1,ENAH,EVL,PAG1
R-HSA-388841	Costimulation by the CD28 family	0.921299028017083	-0.0819706178801998	68	2	0.0040650406504065	492	8202	57761,9020	TRIB3,MAP3K14
R-HSA-199977	ER to Golgi Anterograde Transport	0.921299028017083	-0.0819706178801998	68	2	0.0040650406504065	492	8202	9871,149111	SEC24D,CNIH3
R-HSA-75893	TNF signaling	0.921342707800807	-0.0819232079221121	41	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-373752	Netrin-1 signaling	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	7204	TRIO
R-HSA-73856	RNA Polymerase II Transcription Termination	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-975634	Retinoid metabolism and transport	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	5947	RBP1
R-HSA-375280	Amine ligand-binding receptors	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	3363	HTR7
R-HSA-1566948	Elastic fibre formation	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	652	BMP4
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.926084698712292	-0.0767895812269435	42	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-195258	RHO GTPase Effectors	0.928544333908585	-0.0741371514471108	285	12	0.024390243902439	492	8202	51466,71,3798,8379,1742,348995,23279,114793,23028,23081,10788,401541	EVL,ACTG1,KIF5A,MAD1L1,DLG4,NUP43,NUP160,FMNL2,KDM1A,KDM4C,IQGAP2,CENPP
R-HSA-948021	Transport to the Golgi and subsequent modification	0.930332937676233	-0.0722127593993247	95	3	0.00609756097560976	492	8202	9871,149111,4121	SEC24D,CNIH3,MAN1A1
R-HSA-72172	mRNA Splicing	0.93524819216575	-0.0669433387514729	120	4	0.00813008130081301	492	8202	10946,22916,2521,27339	SF3A3,NCBP2,FUS,PRPF19
R-HSA-5668914	Diseases of metabolism	0.938666190365656	-0.0632953577953942	45	1	0.00203252032520325	492	8202	5095	PCCA
R-HSA-2672351	Stimuli-sensing channels	0.941784947726503	-0.0599783237526195	99	3	0.00609756097560976	492	8202	6262,57719,10110	RYR2,ANO8,SGK2
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.945842336846267	-0.0556793867732779	47	1	0.00203252032520325	492	8202	329	BIRC2
R-HSA-5578749	Transcriptional regulation by small RNAs	0.946833504088545	-0.0546320153096083	101	3	0.00609756097560976	492	8202	348995,23279,27327	NUP43,NUP160,TNRC6A
R-HSA-68886	M Phase	0.947439692458399	-0.0539919931716705	296	12	0.024390243902439	492	8202	10783,10274,9663,10393,8379,5682,348995,5578,23279,7324,7112,401541	NEK6,STAG1,LPIN2,ANAPC10,MAD1L1,PSMA1,NUP43,PRKCA,NUP160,UBE2E1,TMPO,CENPP
R-HSA-199991	Membrane Trafficking	0.948902155138764	-0.0524495888080763	256	10	0.0203252032520325	492	8202	27243,149111,9871,79720,60412,8907,22989,25977,162,92421	CHMP2A,CNIH3,SEC24D,VPS37B,EXOC4,AP1M1,MYH15,NECAP1,AP1B1,CHMP4C
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.949109727433992	-0.0522308627843238	48	1	0.00203252032520325	492	8202	1948	EFNB2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.949202456365638	-0.0521331665966144	102	3	0.00609756097560976	492	8202	2110,4725,6834	ETFDH,NDUFS5,SURF1
R-HSA-211859	Biological oxidations	0.951131101419469	-0.0501033695558677	194	7	0.0142276422764228	492	8202	1591,2678,2941,1800,6819,4257,6916	CYP24A1,GGT1,GSTA4,DPEP1,SULT1C2,MGST1,TBXAS1
R-HSA-390466	Chaperonin-mediated protein folding	0.952180369338872	-0.0490007985454795	49	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.952180369338872	-0.0490007985454795	49	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.952180369338872	-0.0490007985454795	49	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-171306	Packaging Of Telomere Ends	0.952180369338872	-0.0490007985454795	49	1	0.00203252032520325	492	8202	54386	TERF2IP
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.955066087286323	-0.0459747395487748	50	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-169911	Regulation of Apoptosis	0.955066087286323	-0.0459747395487748	50	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-72165	mRNA Splicing - Minor Pathway	0.955066087286323	-0.0459747395487748	50	1	0.00203252032520325	492	8202	22916	NCBP2
R-HSA-1461973	Defensins	0.957777996626121	-0.0431392641646939	51	1	0.00203252032520325	492	8202	5646	PRSS3
R-HSA-180534	Vpu mediated degradation of CD4	0.957777996626121	-0.0431392641646939	51	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.962721556941028	-0.0379910502799879	53	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-114604	GPVI-mediated activation cascade	0.964972261810968	-0.0356559222936135	54	1	0.00203252032520325	492	8202	6464	SHC1
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.964972261810968	-0.0356559222936135	54	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-4641257	Degradation of AXIN	0.964972261810968	-0.0356559222936135	54	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-5389840	Mitochondrial translation elongation	0.965414917486296	-0.0351973037451337	84	2	0.0040650406504065	492	8202	55173,23107	MRPS10,MRPS27
R-HSA-5368286	Mitochondrial translation initiation	0.965414917486296	-0.0351973037451337	84	2	0.0040650406504065	492	8202	55173,23107	MRPS10,MRPS27
R-HSA-72649	Translation initiation complex formation	0.967087338791289	-0.0334664682782369	55	1	0.00203252032520325	492	8202	26986	PABPC1
R-HSA-391251	Protein folding	0.967087338791289	-0.0334664682782369	55	1	0.00203252032520325	492	8202	7846	TUBA1A
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.967087338791289	-0.0334664682782369	55	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.967087338791289	-0.0334664682782369	55	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-72737	Cap-dependent Translation Initiation	0.968043069811541	-0.0324786990884079	112	3	0.00609756097560976	492	8202	8891,6158,26986	EIF2B3,RPL28,PABPC1
R-HSA-72613	Eukaryotic Translation Initiation	0.968043069811541	-0.0324786990884079	112	3	0.00609756097560976	492	8202	8891,6158,26986	EIF2B3,RPL28,PABPC1
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.969074945192477	-0.031413327262279	56	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-4641258	Degradation of DVL	0.969074945192477	-0.031413327262279	56	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.969074945192477	-0.031413327262279	56	1	0.00203252032520325	492	8202	26986	PABPC1
R-HSA-5653656	Vesicle-mediated transport	0.969939573297143	-0.0305215049951135	294	11	0.0223577235772358	492	8202	27243,149111,9871,79720,60412,8907,22989,25977,949,162,92421	CHMP2A,CNIH3,SEC24D,VPS37B,EXOC4,AP1M1,MYH15,NECAP1,SCARB1,AP1B1,CHMP4C
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.970456137772258	-0.0299890728892589	87	2	0.0040650406504065	492	8202	7090,6934	TLE3,TCF7L2
R-HSA-69275	G2/M Transition	0.972261677676908	-0.0281302950367626	115	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.972697956472032	-0.0276816699909968	58	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.973415505366362	-0.0269442526297625	89	2	0.0040650406504065	492	8202	1591,6916	CYP24A1,TBXAS1
R-HSA-453274	Mitotic G2-G2/M phases	0.974775231913473	-0.0255483659315273	117	3	0.00609756097560976	492	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-5625740	RHO GTPases activate PKNs	0.974785869323389	-0.0255374533113392	90	2	0.0040650406504065	492	8202	23028,23081	KDM1A,KDM4C
R-HSA-421270	Cell-cell junction organization	0.977353741746199	-0.0229066231295977	61	1	0.00203252032520325	492	8202	25945	PVRL3
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.977353741746199	-0.0229066231295977	61	1	0.00203252032520325	492	8202	71	ACTG1
R-HSA-2682334	EPH-Ephrin signaling	0.980675807460447	-0.0195133455325278	95	2	0.0040650406504065	492	8202	1948,71	EFNB2,ACTG1
R-HSA-5358346	Hedgehog ligand biogenesis	0.981216916987677	-0.0189617256256819	64	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-913709	O-linked glycosylation of mucins	0.981216916987677	-0.0189617256256819	64	1	0.00203252032520325	492	8202	55568	GALNT10
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.981216916987677	-0.0189617256256819	64	1	0.00203252032520325	492	8202	1308	COL17A1
R-HSA-1236974	ER-Phagosome pathway	0.981216916987677	-0.0189617256256819	64	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-983712	Ion channel transport	0.981838468710354	-0.0183284763063037	198	6	0.0121951219512195	492	8202	535,6262,57719,10110,51076,374868	ATP6V0A1,RYR2,ANO8,SGK2,CUTC,ATP9B
R-HSA-69202	Cyclin E associated events during G1/S transition	0.982352487996877	-0.0178050859541569	65	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.983419536769031	-0.0167194576478109	66	1	0.00203252032520325	492	8202	4793	NFKBIB
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.983419536769031	-0.0167194576478109	66	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.984405809564509	-0.0157170588527152	99	2	0.0040650406504065	492	8202	5682,9020	PSMA1,MAP3K14
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.98441855562993	-0.0157041109578734	127	3	0.00609756097560976	492	8202	348995,6158,23279	NUP43,RPL28,NUP160
R-HSA-446203	Asparagine N-linked glycosylation	0.986371954563256	-0.0137217596496898	181	5	0.0101626016260163	492	8202	9871,149111,8869,4758,4121	SEC24D,CNIH3,ST3GAL5,NEU1,MAN1A1
R-HSA-211000	Gene Silencing by RNA	0.986543203463532	-0.0135481597865544	130	3	0.00609756097560976	492	8202	348995,23279,27327	NUP43,NUP160,TNRC6A
R-HSA-201681	TCF dependent signaling in response to WNT	0.986564397236837	-0.013526677153475	229	7	0.0142276422764228	492	8202	5682,54894,440193,6659,7090,6934,22943	PSMA1,RNF43,CCDC88C,SOX4,TLE3,TCF7L2,DKK1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.987081413639863	-0.0130027569931267	70	1	0.00203252032520325	492	8202	401541	CENPP
R-HSA-774815	Nucleosome assembly	0.987081413639863	-0.0130027569931267	70	1	0.00203252032520325	492	8202	401541	CENPP
R-HSA-5173105	O-linked glycosylation	0.98743274144185	-0.0126468944587508	103	2	0.0040650406504065	492	8202	55568,57188	GALNT10,ADAMTSL3
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.988095176987937	-0.0119762528902508	104	2	0.0040650406504065	492	8202	6158,26986	RPL28,PABPC1
R-HSA-2871837	FCERI mediated NF-kB activation	0.991655224641584	-0.00837978791363576	77	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.993470130902215	-0.00655128195935834	115	2	0.0040650406504065	492	8202	10666,1525	CD226,CXADR
R-HSA-1236975	Antigen processing-Cross presentation	0.993500476149176	-0.00652073772598539	81	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-192823	Viral mRNA Translation	0.994611777681207	-0.00540279114562275	84	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-156902	Peptide chain elongation	0.994611777681207	-0.00540279114562275	84	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-5632684	Hedgehog 'on' state	0.994611777681207	-0.00540279114562275	84	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-72764	Eukaryotic Translation Termination	0.994938336600585	-0.00507451700970973	85	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.995245141876634	-0.00476619842321062	86	1	0.00203252032520325	492	8202	71	ACTG1
R-HSA-977225	Amyloid formation	0.9958041900643	-0.00420463704611288	88	1	0.00203252032520325	492	8202	4240	MFGE8
R-HSA-156842	Eukaryotic Translation Elongation	0.9958041900643	-0.00420463704611288	88	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-72689	Formation of a pool of free 40S subunits	0.997117511365616	-0.00288665100533031	94	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-202424	Downstream TCR signaling	0.997456741338634	-0.00254649823756123	96	1	0.00203252032520325	492	8202	5682	PSMA1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.998552820969965	-0.00144822720499442	105	1	0.00203252032520325	492	8202	6158	RPL28
R-HSA-162582	Signal Transduction	0.999593655422605	-0.000406427157723816	2357	110	0.223577235772358	492	8202	23092,200734,26052,154810,71,3798,5786,4923,54903,4647,54894,348995,100288637,5578,23279,57406,5881,329,55824,5139,23028,182,6464,93663,8651,51377,8379,7414,11343,2787,843,5567,5796,55534,283869,51466,4893,79971,1742,535,6659,2260,2770,3363,4088,54331,58480,6498,817,5533,8829,5947,27327,4208,55081,673,10435,2308,2335,7204,5142,4092,57142,9252,7048,10788,10019,5583,10846,79659,51384,440193,114793,6709,6199,2254,5829,8831,5141,2247,7090,7976,58513,11069,157506,5908,5682,84033,23286,23365,3570,9743,5138,1374,5140,23236,6934,22943,401541,3667,57761,221955,56937,57539,94134,101928168,6907,5576,23081,6789	ARHGAP26,SPRED2,DNM3,AMOTL1,ACTG1,KIF5A,PTPRA,NTSR1,MKS1,MYO7A,RNF43,NUP43,LOC100288637,PRKCA,NUP160,ABHD6,RAC3,BIRC2,PAG1,PDE3A,KDM1A,JAG1,SHC1,ARHGAP18,SOCS1,UCHL5,MAD1L1,VCL,MGLL,GNG5,CASP10,PRKACB,PTPRK,MAML3,NPW,EVL,NRAS,WLS,DLG4,ATP6V0A1,SOX4,FGFR1,GNAI1,HTR7,SMAD3,GNG2,RHOU,SKIL,CAMK2D,PPP3CC,NRP1,RBP1,TNRC6A,MEF2C,IFT57,BRAF,CDC42EP2,FOXO1,FN1,TRIO,PDE4B,SMAD7,RTN4,RPS6KA5,TGFBR2,IQGAP2,SH2B3,PRKCH,PDE10A,DYNC2H1,WNT16,CCDC88C,FMNL2,SPTAN1,RPS6KB2,FGF9,PXN,SYNGAP1,PDE4A,FGF2,TLE3,FZD3,EPS15L1,RAPGEF4,RDH10,RAP1B,PSMA1,OBSCN,WWC1,ARHGEF12,IL6R,ARHGAP32,PDE2A,CPT1A,PDE3B,PLCB1,TCF7L2,DKK1,CENPP,IRS1,TRIB3,DAGLB,PMEPA1,WDR35,ARHGAP12,LOC101928168,TBL1X,PRKAR2A,KDM4C,STK4
R-HSA-418594	G alpha (i) signalling events	0.999725370488283	-0.000274667229306671	236	4	0.00813008130081301	492	8202	54331,283869,2787,2770	GNG2,NPW,GNG5,GNAI1
R-HSA-375276	Peptide ligand-binding receptors	0.999923112132464	-7.68908235598124e-05	193	2	0.0040650406504065	492	8202	283869,4923	NPW,NTSR1
R-HSA-372790	Signaling by GPCR	0.999992803586782	-7.19643911264335e-06	1230	43	0.0873983739837398	492	8202	200734,673,2335,5786,4923,7204,5142,5578,57406,5139,5583,6464,10846,51384,7414,11343,2787,5567,6709,283869,2254,4893,8831,5141,2247,7976,5908,5682,1742,84033,23365,5138,5140,23236,2260,2770,3363,54331,3667,817,221955,5533,5576	SPRED2,BRAF,FN1,PTPRA,NTSR1,TRIO,PDE4B,PRKCA,ABHD6,PDE3A,PRKCH,SHC1,PDE10A,WNT16,VCL,MGLL,GNG5,PRKACB,SPTAN1,NPW,FGF9,NRAS,SYNGAP1,PDE4A,FGF2,FZD3,RAP1B,PSMA1,DLG4,OBSCN,ARHGEF12,PDE2A,PDE3B,PLCB1,FGFR1,GNAI1,HTR7,GNG2,IRS1,CAMK2D,DAGLB,PPP3CC,PRKAR2A
R-HSA-500792	GPCR ligand binding	0.999999364622812	-6.3537738960765e-07	444	7	0.0142276422764228	492	8202	3363,54331,283869,51384,2787,7976,4923	HTR7,GNG2,NPW,WNT16,GNG5,FZD3,NTSR1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999999531396183	-4.68603926902251e-07	318	3	0.00609756097560976	492	8202	3363,283869,4923	HTR7,NPW,NTSR1
R-HSA-388396	GPCR downstream signaling	0.99999998888795	-1.11120498768256e-08	928	22	0.0447154471544715	492	8202	283869,5141,4923,7204,5142,84033,23365,5138,5578,23236,5140,57406,5139,2770,3363,54331,5583,6464,221955,10846,11343,2787	NPW,PDE4A,NTSR1,TRIO,PDE4B,OBSCN,ARHGEF12,PDE2A,PRKCA,PLCB1,PDE3B,ABHD6,PDE3A,GNAI1,HTR7,GNG2,PRKCH,SHC1,DAGLB,PDE10A,MGLL,GNG5
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-193639	p75NTR signals via NF-kB	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999982963	-1.70368388905551e-11	16	0	0	492	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-68952	DNA replication initiation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-70921	Histidine catabolism	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-388479	Vasopressin-like receptors	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-500753	Pyrimidine biosynthesis	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-171052	LDL-mediated lipid transport	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-176417	Phosphorylation of Emi1	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-1237112	Methionine salvage pathway	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-171319	Telomere Extension By Telomerase	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-174362	Transport and synthesis of PAPS	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-205025	NADE modulates death signalling	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-111957	Cam-PDE 1 activation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-187015	Activation of TRKA receptors	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-428808	Na+-dependent glucose transporters	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-444257	RSK activation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-166662	Lectin pathway of complement activation	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.99999999998381	-1.61902594907331e-11	6	0	0	492	8202
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999984155	-1.58445861120597e-11	19	0	0	492	8202
R-HSA-190861	Gap junction assembly	0.999999999984155	-1.58445861120597e-11	19	0	0	492	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999984155	-1.58445861120597e-11	19	0	0	492	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999984155	-1.58445861120597e-11	19	0	0	492	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5653890	Lactose synthesis	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-70350	Fructose catabolism	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-77108	Utilization of Ketone Bodies	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-193681	Ceramide signalling	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-198745	Signalling to STAT3	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1296067	Potassium transport channels	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-351200	Interconversion of polyamines	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999984812	-1.51875422774086e-11	3	0	0	492	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-916853	Degradation of GABA	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-168268	Virus Assembly and Release	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-1483101	Synthesis of PS	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-192905	vRNP Assembly	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-844623	The IPAF inflammasome	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-380612	Metabolism of serotonin	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-156582	Acetylation	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-888568	GABA synthesis	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-198765	Signalling to ERK5	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-70688	Proline catabolism	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-187042	TRKA activation by NGF	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-75094	Formation of the Editosome	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-1483226	Synthesis of PI	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999985308	-1.46922140252526e-11	2	0	0	492	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-428540	Activation of Rac	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-69166	Removal of the Flap Intermediate	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.99999999998598	-1.40202844243666e-11	14	0	0	492	8202
R-HSA-3322077	Glycogen synthesis	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-211935	Fatty acids	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-975577	N-Glycan antennae elongation	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999986984	-1.30159387859308e-11	15	0	0	492	8202
R-HSA-166663	Initial triggering of complement	0.999999999987222	-1.27781498169976e-11	20	0	0	492	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-389542	NADPH regeneration	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-3248023	Regulation by TREX1	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-169131	Inhibition of PKR	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1483076	Synthesis of CL	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-140180	COX reactions	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-1300645	Acrosome Reaction	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5619084	ABC transporter disorders	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999987868	-1.21322396573476e-11	1	0	0	492	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-419771	Opsins	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-5621480	Dectin-2 family	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-190873	Gap junction degradation	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-2161522	Abacavir transport and metabolism	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999989308	-1.06920639491682e-11	10	0	0	492	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-209776	Amine-derived hormones	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-912631	Regulation of signaling by CBL	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-5635838	Activation of SMO	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999990429	-9.57124143253768e-12	18	0	0	492	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-5652084	Fructose metabolism	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-2161541	Abacavir metabolism	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-446205	Synthesis of GDP-mannose	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-167827	The proton buffering model	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-2161517	Abacavir transmembrane transport	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-444209	Free fatty acid receptors	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-70370	Galactose catabolism	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-197264	Nicotinamide salvaging	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-390651	Dopamine receptors	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-187024	NGF-independant TRKA activation	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-157881	Cyclin B2 mediated events	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-111463	SMAC binds to IAPs	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-561048	Organic anion transport	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-391906	Leukotriene receptors	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-68911	G2 Phase	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-112307	Transmission across Electrical Synapses	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-167826	The fatty acid cycling model	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999992214	-7.78600029474141e-12	5	0	0	492	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999992304	-7.6961757085631e-12	24	0	0	492	8202
R-HSA-977606	Regulation of Complement cascade	0.999999999992304	-7.6961757085631e-12	24	0	0	492	8202
R-HSA-879518	Transport of organic anions	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-376172	DSCAM interactions	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-199997	COPI Mediated Transport	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-71064	Lysine catabolism	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-211999	CYP2E1 reactions	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-193048	Androgen biosynthesis	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-71240	Tryptophan catabolism	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-196807	Nicotinate metabolism	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999992752	-7.24777081457759e-12	11	0	0	492	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999994402	-5.59828030859204e-12	22	0	0	492	8202
R-HSA-381753	Olfactory Signaling Pathway	0.999999999995301	-4.69923850640368e-12	381	0	0	492	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-164944	Nef and signal transduction	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-428643	Organic anion transporters	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-73928	Depyrimidination	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-804914	Transport of fatty acids	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-444821	Relaxin receptors	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-1483148	Synthesis of PG	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999995517	-4.4832796470783e-12	8	0	0	492	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-156587	Amino Acid conjugation	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-70635	Urea cycle	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-390696	Adrenoceptors	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999996156	-3.84358582198155e-12	9	0	0	492	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-71262	Carnitine synthesis	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-173736	Alternative complement activation	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1296061	HCN channels	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-75072	mRNA Editing	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1296053	Classical Kir channels	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-6783984	Glycine degradation	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-888593	Reuptake of GABA	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-209563	Axonal growth stimulation	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-428776	Class II GLUTs	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-442745	Activation of CaMK IV	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-390650	Histamine receptors	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-167060	NGF processing	0.999999999996498	-3.5018602821251e-12	4	0	0	492	8202
R-HSA-1251985	Nuclear signaling by ERBB4	0.999999999997844	-2.15586121423276e-12	40	0	0	492	8202
R-HSA-5334118	DNA methylation	0.999999999998115	-1.88464361954076e-12	62	0	0	492	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.99999999999876	-1.24037477980065e-12	27	0	0	492	8202
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.99999999999876	-1.24037477980065e-12	27	0	0	492	8202
R-HSA-1461957	Beta defensins	1.00000000000022	2.23005411948007e-13	42	0	0	492	8202
R-HSA-70895	Branched-chain amino acid catabolism	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-389948	PD-1 signaling	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-5627123	RHO GTPases activate PAKs	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-211976	Endogenous sterols	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	1.00000000000131	1.30608600192216e-12	23	0	0	492	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-622312	Inflammasomes	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-140534	Ligand-dependent caspase activation	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-69205	G1/S-Specific Transcription	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-432142	Platelet sensitization by LDL	1.0000000000023	2.30012880076673e-12	17	0	0	492	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-429593	Inositol transporters	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-74182	Ketone body metabolism	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-2214320	Anchoring fibril formation	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000317	3.16500331664287e-12	7	0	0	492	8202
R-HSA-446652	Interleukin-1 signaling	1.00000000000381	3.80743747192225e-12	44	0	0	492	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	1.00000000000405	4.05161008992366e-12	31	0	0	492	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-209560	NF-kB is activated and signals survival	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-2029481	FCGR activation	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-977441	GABA A receptor activation	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-209543	p75NTR recruits signalling complexes	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-209822	Glycoprotein hormones	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000000549	5.48753246649603e-12	13	0	0	492	8202
R-HSA-113510	E2F mediated regulation of DNA replication	1.00000000000573	5.72561014800676e-12	33	0	0	492	8202
R-HSA-1638074	Keratan sulfate/keratin metabolism	1.00000000000573	5.72561014800676e-12	33	0	0	492	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-156581	Methylation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-203615	eNOS activation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-3371511	HSF1 activation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-3656237	Defective EXT2 causes exostoses 2	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-210990	PECAM1 interactions	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-71384	Ethanol oxidation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-211958	Miscellaneous substrates	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-417957	P2Y receptors	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-202670	ERKs are inactivated	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000000674	6.73951925532017e-12	12	0	0	492	8202
R-HSA-1474165	Reproduction	1.0000000000082	8.19545633663555e-12	26	0	0	492	8202
R-HSA-975298	Ligand-gated ion channel transport	1.0000000000082	8.19545633663555e-12	26	0	0	492	8202
R-HSA-2029485	Role of phospholipids in phagocytosis	1.0000000000082	8.19545633663555e-12	26	0	0	492	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.0000000000082	8.19545633663555e-12	26	0	0	492	8202
R-HSA-1187000	Fertilization	1.0000000000082	8.19545633663555e-12	26	0	0	492	8202
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.00000000000827	8.27408464617542e-12	38	0	0	492	8202
R-HSA-166658	Complement cascade	1.00000000000827	8.27408464617542e-12	38	0	0	492	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000000868	8.67530392155752e-12	30	0	0	492	8202
R-HSA-420029	Tight junction interactions	1.00000000000868	8.67530392155752e-12	30	0	0	492	8202
R-HSA-2022854	Keratan sulfate biosynthesis	1.00000000000899	8.98614869188139e-12	28	0	0	492	8202
R-HSA-190828	Gap junction trafficking	1.00000000000899	8.98614869188139e-12	28	0	0	492	8202
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.00000000000899	8.98614869188139e-12	28	0	0	492	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000000998	9.98433523382486e-12	48	0	0	492	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000001065	1.06538278914182e-11	65	0	0	492	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-977068	Termination of O-glycan biosynthesis	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-1538133	G0 and Early G1	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-3295583	TRP channels	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-2262749	Cellular response to hypoxia	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	1.00000000001095	1.09534717082973e-11	25	0	0	492	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000001123	1.12251642601076e-11	39	0	0	492	8202
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000001123	1.12251642601076e-11	39	0	0	492	8202
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000001123	1.12251642601076e-11	39	0	0	492	8202
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	1.00000000001123	1.12251642601076e-11	39	0	0	492	8202
R-HSA-165159	mTOR signalling	1.00000000001123	1.12251642601076e-11	39	0	0	492	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000001196	1.19561751539715e-11	60	0	0	492	8202
R-HSA-3928663	EPHA-mediated growth cone collapse	1.00000000001415	1.41549472205269e-11	34	0	0	492	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001611	1.61078958841649e-11	29	0	0	492	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001611	1.61078958841649e-11	29	0	0	492	8202
R-HSA-211981	Xenobiotics	1.00000000001638	1.63837273428477e-11	21	0	0	492	8202
R-HSA-2024096	HS-GAG degradation	1.00000000001638	1.63837273428477e-11	21	0	0	492	8202
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000001638	1.63837273428477e-11	21	0	0	492	8202
R-HSA-156588	Glucuronidation	1.00000000001638	1.63837273428477e-11	21	0	0	492	8202
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000001858	1.85766649649908e-11	70	0	0	492	8202
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000002079	2.07913031579894e-11	55	0	0	492	8202
R-HSA-2299718	Condensation of Prophase Chromosomes	1.0000000000232	2.31997997167012e-11	71	0	0	492	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000002374	2.3741132769145e-11	56	0	0	492	8202
